|
G |
Abcf1 |
ATP binding cassette subfamily F member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955583:600,381...607,211
Ensembl chrNW_004955583:600,398...606,820
|
|
G |
Agt |
angiotensinogen |
susceptibility |
ISO |
DNA:polymorphism: :p.M235T (human) |
RGD |
PMID:10200023 |
RGD:8142344 |
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8431628 |
|
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Bcl2a1 |
BCL2 related protein A1 |
|
ISO |
|
RGD |
PMID:11733571 |
RGD:734640 |
NCBI chrNW_004955533:773,912...785,040
Ensembl chrNW_004955533:773,912...785,037
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955433:15,052,616...15,054,732
Ensembl chrNW_004955433:15,053,061...15,054,572
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955472:1,444,598...1,446,488
Ensembl chrNW_004955472:1,444,316...1,446,490
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955453:6,846,625...6,850,007
Ensembl chrNW_004955453:6,846,549...6,850,031
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955456:14,582,812...14,588,574
Ensembl chrNW_004955456:14,583,610...14,585,169
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955420:25,641,184...25,664,413
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955439:14,921,524...14,949,493
Ensembl chrNW_004955439:14,920,601...14,924,191
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955420:26,083,445...26,093,740
Ensembl chrNW_004955420:26,083,040...26,093,775
|
|
G |
Cd14 |
CD14 molecule |
resistance |
ISO |
DNA:polymorphism:promoter:c. -159C>T (human) |
RGD |
PMID:19222419 |
RGD:4144798 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20488241 PMID:23624239 |
|
NCBI chrNW_004955434:9,487,309...9,508,366
Ensembl chrNW_004955434:9,487,315...9,505,904
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22216203 |
|
NCBI chrNW_004955424:21,962,837...22,067,745
Ensembl chrNW_004955424:21,927,079...22,050,371
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955433:15,023,272...15,034,650
Ensembl chrNW_004955433:15,023,050...15,034,711
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955433:724,566...731,945
Ensembl chrNW_004955433:724,515...732,192
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955475:11,148,928...11,152,313
Ensembl chrNW_004955475:11,148,879...11,152,596
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
severity |
ISO |
DNA:SNP: :927T>C (human) |
RGD |
PMID:16776674 |
RGD:4782072 |
NCBI chrNW_004955557:1,667,518...1,702,272
|
|
G |
Dsg1 |
desmoglein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23974871 |
|
NCBI chrNW_004955402:18,668,717...18,704,329
Ensembl chrNW_004955402:18,668,196...18,700,630
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27965764 |
|
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:20526719 |
RGD:5133266 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
associated with Giardiasis;protein:increased expression:serum |
RGD |
PMID:7524984 PMID:15587302 |
RGD:8158114 RGD:8547689 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:10886234 PMID:21625544 |
|
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
DNA:SNP:promoter, 3' utr:-1055C>T, 4738G>A (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11588017 PMID:21625544 |
RGD:4765128 |
NCBI chrNW_004955408:4,046,406...4,049,795
|
|
G |
Il16 |
interleukin 16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23624239 |
|
NCBI chrNW_004955416:11,876,317...11,987,548
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955470:7,685,498...7,703,374
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955470:7,518,565...7,562,219
Ensembl chrNW_004955470:7,518,663...7,559,470
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:21509781 |
RGD:5147912 |
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955413:23,623,567...23,640,245
Ensembl chrNW_004955413:23,623,154...23,640,259
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16095146 PMID:21625544 |
|
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955421:10,211,594...10,259,760
Ensembl chrNW_004955421:10,221,694...10,259,885
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955446:11,790,636...11,837,734
Ensembl chrNW_004955446:11,790,444...11,835,001
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955407:41,779,849...41,805,637
Ensembl chrNW_004955407:41,777,777...41,800,201
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11160071 |
|
NCBI chrNW_004955420:20,989,197...21,016,084
|
|
G |
LOC102010850 |
cytochrome P450 1A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19022366 |
|
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
|
|
G |
LOC102019320 |
mamu class II histocompatibility antigen, DR alpha chain |
|
ISO |
|
RGD |
PMID:9104792 |
RGD:5490205 |
NCBI chrNW_004955437:1,109,735...1,114,742
Ensembl chrNW_004955437:1,109,713...1,114,802
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
DNA:polymorphism, haplotype associated with Nasal Polyps |
RGD |
PMID:11591192 PMID:22545387 |
RGD:8548785 RGD:8548802 |
NCBI chrNW_004955437:114,216...116,003
Ensembl chrNW_004955437:114,640...115,529
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21544193 |
|
NCBI chrNW_004955478:3,331,607...3,448,840
Ensembl chrNW_004955478:3,331,607...3,448,842
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
DNA:polymorphisms:promoter: |
RGD |
PMID:14962818 |
RGD:4891046 |
NCBI chrNW_004955455:8,367,566...8,368,460
Ensembl chrNW_004955455:8,367,566...8,368,460
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16766537 |
|
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15621374 |
|
NCBI chrNW_004955427:22,760,432...23,008,432
Ensembl chrNW_004955427:22,762,221...22,970,508
|
|
G |
Selp |
selectin P |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12929084 |
|
NCBI chrNW_004955462:7,658,371...7,692,870
Ensembl chrNW_004955462:7,652,437...7,693,994
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
|
|
G |
Tac1 |
tachykinin precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11160071 |
|
NCBI chrNW_004955432:13,991,647...13,999,665
Ensembl chrNW_004955432:13,991,414...13,999,728
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
|
ISO |
DNA:polymorphism, haplotype: :p.V333I (human) |
RGD |
PMID:11591192 |
RGD:8548785 |
NCBI chrNW_004955437:1,504,549...1,511,110
Ensembl chrNW_004955437:1,504,947...1,511,097
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19138248 PMID:21625544 |
|
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16095146 PMID:21625544 |
|
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chrNW_004955486:1,790,531...1,817,986
Ensembl chrNW_004955486:1,792,115...1,818,362
|
|
|
G |
F12 |
coagulation factor XII |
disease_progression |
ISO |
|
RGD |
PMID:9129025 |
RGD:11565081 |
NCBI chrNW_004955408:29,644,279...29,665,161
Ensembl chrNW_004955408:29,642,096...29,650,950
|
|
G |
F2 |
coagulation factor II, thrombin |
disease_progression |
ISO |
protein:increased expression:plasma: |
RGD |
PMID:9129025 |
RGD:11565081 |
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
|
|
G |
F7 |
coagulation factor VII |
disease_progression |
ISO |
|
RGD |
PMID:9129025 |
RGD:11565081 |
NCBI chrNW_004955404:685,170...692,797
Ensembl chrNW_004955404:680,594...693,665
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO |
ClinVar Annotator: match by term: Susceptibility to angioedema induced by ACE inhibitors |
ClinVar |
PMID:1551674 PMID:1972698 PMID:1978554 PMID:1978555 PMID:2503817 PMID:2912069 PMID:3393536 PMID:4974311 PMID:5305539 PMID:5369703 PMID:6698555 PMID:7203486 PMID:8611726 PMID:8860013 PMID:9342374 PMID:11445808 PMID:12768444 PMID:14278484 PMID:15315792 PMID:15502081 PMID:16119988 PMID:19594365 PMID:22018328 PMID:22906047 PMID:23479361 PMID:24460025 PMID:24586352 PMID:25326637 PMID:25741868 PMID:28492532 PMID:32860008 More...
|
|
NCBI chrNW_004955580:1,045,294...1,058,129
Ensembl chrNW_004955580:1,045,294...1,057,083
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9734886 |
|
NCBI chrNW_004955420:20,989,197...21,016,084
|
|
G |
Serping1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:9734886 PMID:23406939 |
|
NCBI chrNW_004955511:2,545,337...2,557,850
Ensembl chrNW_004955511:2,545,285...2,557,982
|
|
G |
Xpnpep2 |
X-prolyl aminopeptidase 2 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Susceptibility to angioedema induced by ACE inhibitors |
OMIM ClinVar |
PMID:16175507 PMID:20625347 PMID:21898657 |
|
NCBI chrNW_004955473:5,248,065...5,274,469
Ensembl chrNW_004955473:5,245,746...5,274,698
|
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
treatment |
ISO |
|
RGD |
PMID:30059697 |
RGD:39939057 |
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
treatment |
ISO |
|
RGD |
PMID:25530546 |
RGD:11081163 |
NCBI chrNW_004955456:14,554,583...14,558,967
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
treatment |
ISO |
|
RGD |
PMID:23933317 |
RGD:40903070 |
NCBI chrNW_004955557:1,667,518...1,702,272
|
|
G |
Epx |
eosinophil peroxidase |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:11846868 |
RGD:13506893 |
NCBI chrNW_004955451:4,818,809...4,828,913
Ensembl chrNW_004955451:4,818,809...4,828,913
|
|
G |
Il25 |
interleukin 25 |
treatment |
ISO |
|
RGD |
PMID:17889290 |
RGD:40902975 |
NCBI chrNW_004955409:36,960,902...36,964,038
Ensembl chrNW_004955409:36,961,398...36,964,038
|
|
G |
LOC102025724 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
susceptibility |
ISO |
DNA:polymorphism: |
RGD |
PMID:28380482 |
RGD:13506910 |
NCBI chrNW_004955437:1,644,037...1,657,094
Ensembl chrNW_004955437:1,643,238...1,651,071
|
|
G |
LOC102026469 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
DNA:polymorphism: |
RGD |
PMID:28380482 |
RGD:13506910 |
NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042
|
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
associated with Cystic Fibrosis |
RGD |
PMID:17898016 |
RGD:4145612 |
NCBI chrNW_004955433:15,052,616...15,054,732
Ensembl chrNW_004955433:15,053,061...15,054,572
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:10946288 |
RGD:8661731 |
NCBI chrNW_004955420:25,641,184...25,664,413
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
ISO |
DNA:mutations: : |
RGD |
PMID:11243954 |
RGD:4140482 |
NCBI chrNW_004955432:23,179,645...23,328,347
Ensembl chrNW_004955432:23,178,866...23,328,382
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:7743671 |
RGD:8547590 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human) |
RGD |
PMID:11474427 PMID:16487239 |
RGD:4889577 RGD:8693711 |
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
|
|
G |
Tlr9 |
toll like receptor 9 |
susceptibility |
ISO |
DNA:SNP:promoter:g.-1237T>C (rs5743836) (human) |
RGD |
PMID:18275280 PMID:18936185 |
RGD:5130858 RGD:5130863 |
NCBI chrNW_004955532:3,828,645...3,832,699
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
susceptibility |
ISO |
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human) |
RGD |
PMID:20646338 |
RGD:5131174 |
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:conjunctiva |
RGD |
PMID:12682842 |
RGD:2307196 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:18658092 |
RGD:6893389 |
NCBI chrNW_004955420:25,702,917...25,723,269
Ensembl chrNW_004955420:25,701,407...25,723,353
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:8766745 |
RGD:8547686 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Ifng |
interferon gamma |
|
ISO |
|
RGD |
PMID:12234900 PMID:16123425 |
RGD:8142386 RGD:8142391 |
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
protein:increased expression:tear |
RGD |
PMID:15144463 PMID:16914468 PMID:19060266 PMID:22092652 |
RGD:11041889 RGD:7364837 RGD:7365027 RGD:7365076 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
associated with Allergic Rhinitis;DNA:SNPs, haplotype:promoter, exon:-1112C>T (rs1800925), p.R130Q (rs20541) (human) |
RGD |
PMID:9191598 PMID:22023794 |
RGD:8549533 RGD:8549595 |
NCBI chrNW_004955408:4,046,406...4,049,795
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO |
|
RGD |
PMID:9326725 |
RGD:7401198 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
human protein in a mouse model |
RGD |
PMID:10549671 |
RGD:8549802 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Il4r |
interleukin 4 receptor |
susceptibility |
ISO |
associated with rhinitis; DNA:SNP: : rs2107356 (human) |
RGD |
PMID:20002627 |
RGD:4890389 |
NCBI chrNW_004955493:5,546,340...5,580,745
Ensembl chrNW_004955493:5,545,944...5,582,422
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:14605445 |
RGD:5128787 |
NCBI chrNW_004955408:3,882,282...3,887,965
Ensembl chrNW_004955408:3,880,155...3,887,973
|
|
G |
Lck |
LCK proto-oncogene, Src family tyrosine kinase |
|
ISO |
protein:increased phosphorylation:T cell |
RGD |
PMID:14507881 |
RGD:1600225 |
NCBI chrNW_004955452:10,608,317...10,632,310
Ensembl chrNW_004955452:10,608,318...10,632,310
|
|
G |
Muc1 |
mucin 1, cell surface associated |
severity |
ISO |
|
RGD |
PMID:17177679 |
RGD:7349351 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
severity |
ISO |
|
RGD |
PMID:17177679 |
RGD:7349351 |
NCBI chrNW_004955476:11,108,826...11,135,697
|
|
G |
Muc4 |
mucin 4, cell surface associated |
severity |
ISO |
|
RGD |
PMID:11581187 PMID:17177679 |
RGD:7349351 RGD:7349400 |
NCBI chrNW_004955420:12,228,801...12,274,840
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:16914468 |
RGD:11041889 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
associated with Staphylococcal Infections; |
RGD |
PMID:19358332 |
RGD:8552826 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
mRNA,protein:increased expression:conjunctiva: |
RGD |
PMID:16023216 PMID:21391988 PMID:21820713 |
RGD:7777131 RGD:7794770 RGD:7794849 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tlr9 |
toll like receptor 9 |
|
ISO |
mRNA,protein:decreased expression:conjunctiva: |
RGD |
PMID:16023216 |
RGD:7794849 |
NCBI chrNW_004955532:3,828,645...3,832,699
|
|
G |
Tnc |
tenascin C |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:18305139 |
RGD:4889589 |
NCBI chrNW_004955419:12,569,620...12,662,897
Ensembl chrNW_004955419:12,569,547...12,662,958
|
|
|
G |
Abca6 |
ATP binding cassette subfamily A member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955478:3,639,817...3,706,115
Ensembl chrNW_004955478:3,639,781...3,707,449
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955465:6,053,600...6,201,254
Ensembl chrNW_004955465:6,054,931...6,200,377
|
|
G |
Calcrl |
calcitonin receptor like receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955403:11,016,753...11,118,494
Ensembl chrNW_004955403:11,080,874...11,118,494
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955403:322,082...348,591
Ensembl chrNW_004955403:322,555...347,053
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
|
RGD |
PMID:15491423 |
RGD:1626251 |
NCBI chrNW_004955433:15,052,616...15,054,732
Ensembl chrNW_004955433:15,053,061...15,054,572
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17597826 |
|
NCBI chrNW_004955472:1,444,598...1,446,488
Ensembl chrNW_004955472:1,444,316...1,446,490
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased expression:ear (mouse) |
RGD |
PMID:15491423 |
RGD:1626251 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10899907 PMID:17374397 |
RGD:8661227 |
NCBI chrNW_004955420:25,641,184...25,664,413
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:22075493 |
RGD:6892916 |
NCBI chrNW_004955420:25,702,917...25,723,269
Ensembl chrNW_004955420:25,701,407...25,723,353
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955410:5,003,720...5,120,903
Ensembl chrNW_004955410:5,003,668...5,075,313
|
|
G |
Cd3d |
CD3d molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17597826 |
|
NCBI chrNW_004955412:19,481,059...19,484,890
Ensembl chrNW_004955412:19,480,977...19,484,721
|
|
G |
Cidec |
cell death inducing DFFA like effector c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955561:1,363,907...1,376,144
|
|
G |
Cish |
cytokine inducible SH2 containing protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955532:2,380,380...2,386,000
Ensembl chrNW_004955532:2,378,088...2,386,000
|
|
G |
Cntn3 |
contactin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17597826 |
|
NCBI chrNW_004955421:13,688,779...14,008,546
Ensembl chrNW_004955421:13,764,522...14,008,996
|
|
G |
Crem |
cAMP responsive element modulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955462:2,491,504...2,547,587
Ensembl chrNW_004955462:2,491,504...2,536,385
|
|
G |
Ctsc |
cathepsin C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955414:5,062,355...5,092,631
Ensembl chrNW_004955414:5,062,355...5,092,154
|
|
G |
Emb |
embigin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955446:16,716,677...16,757,031
Ensembl chrNW_004955446:16,716,677...16,753,841
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955407:37,747,152...37,764,170
Ensembl chrNW_004955407:37,747,000...37,765,237
|
|
G |
F13a1 |
coagulation factor XIII A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955465:7,444,118...7,617,366
Ensembl chrNW_004955465:7,443,166...7,617,436
|
|
G |
Fgl2 |
fibrinogen like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955410:7,899,263...7,903,499
Ensembl chrNW_004955410:7,899,309...7,902,722
|
|
G |
Flt1 |
fms related receptor tyrosine kinase 1 |
|
ISO |
mRNA:protein:skin: |
RGD |
PMID:7876550 |
RGD:7421586 |
NCBI chrNW_004955497:7,653,309...7,831,737
Ensembl chrNW_004955497:7,653,248...7,831,472
|
|
G |
Fyb1 |
FYN binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955426:23,621,355...23,777,086
Ensembl chrNW_004955426:23,622,004...23,717,454
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955422:18,173,438...18,192,357
Ensembl chrNW_004955422:18,170,616...18,192,412
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955489:2,500,928...2,524,715
Ensembl chrNW_004955489:2,497,680...2,524,805
|
|
G |
Ifi30 |
IFI30 lysosomal thiol reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17597826 |
|
NCBI chrNW_004955524:3,229,024...3,230,955
Ensembl chrNW_004955524:3,229,257...3,231,825
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11312644 PMID:12484431 PMID:15347381 |
|
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Igsf6 |
immunoglobulin superfamily member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955493:1,109,910...1,119,806
Ensembl chrNW_004955493:1,110,843...1,119,765
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15347381 PMID:23760007 |
RGD:7364806 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
mRNA:increased expression:skin CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9781803 PMID:12874202 PMID:27585668 |
RGD:8655902 RGD:8655940 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il18bp |
interleukin 18 binding protein |
treatment |
ISO |
|
RGD |
PMID:12874202 |
RGD:8655940 |
NCBI chrNW_004955414:19,327,828...19,332,577
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23178550 |
|
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11312644 PMID:22245253 |
|
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955421:22,642,004...22,694,729
Ensembl chrNW_004955421:22,641,511...22,694,913
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12484431 PMID:21804303 |
|
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15347381 |
|
NCBI chrNW_004955408:3,937,128...3,951,784
Ensembl chrNW_004955408:3,937,894...3,939,358
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955439:7,666,246...7,836,481
Ensembl chrNW_004955439:7,756,126...7,836,542
|
|
G |
Itgam |
integrin subunit alpha M |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955493:8,116,886...8,160,806
Ensembl chrNW_004955493:8,116,834...8,260,759
|
|
G |
Jam2 |
junctional adhesion molecule 2 |
|
ISO |
|
RGD |
PMID:16297198 |
RGD:7488919 |
NCBI chrNW_004955407:25,531,891...25,599,551
Ensembl chrNW_004955407:25,571,570...25,599,551
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
|
ISO |
|
RGD |
PMID:16297198 |
RGD:7488919 |
NCBI chrNW_004955412:34,901,850...34,967,394
Ensembl chrNW_004955412:34,901,681...34,967,394
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
mRNA:protein:skin: |
RGD |
PMID:7876550 |
RGD:7421586 |
NCBI chrNW_004955447:15,810,816...15,851,702
Ensembl chrNW_004955447:15,810,815...15,853,583
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955406:10,496,102...10,527,181
Ensembl chrNW_004955406:10,493,379...10,527,201
|
|
G |
LOC102010850 |
cytochrome P450 1A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11312644 PMID:19022366 |
|
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955451:17,013,180...17,022,131
Ensembl chrNW_004955451:17,012,982...17,022,186
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
|
RGD |
PMID:21294775 |
RGD:6483538 |
NCBI chrNW_004955477:5,847,288...5,875,970
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
mRNA:increased expression:skin, lymph node |
RGD |
PMID:10359808 PMID:10415717 PMID:16977379 |
RGD:2325935 RGD:8547869 RGD:8693317 |
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Mrc1 |
mannose receptor C-type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955429:10,139,398...10,232,541
Ensembl chrNW_004955429:10,139,355...10,232,600
|
|
G |
Mxd1 |
MAX dimerization protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955424:15,209,609...15,235,396
Ensembl chrNW_004955424:15,209,609...15,235,667
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955410:10,717,664...10,742,109
Ensembl chrNW_004955410:10,717,664...10,751,177
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23564646 |
|
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Ninj1 |
ninjurin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955515:4,892,748...4,905,627
Ensembl chrNW_004955515:4,892,039...4,907,323
|
|
G |
Numa1 |
nuclear mitotic apparatus protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955414:19,252,191...19,327,504
Ensembl chrNW_004955414:19,252,191...19,327,504
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
|
RGD |
PMID:15677345 |
RGD:8657146 |
NCBI chrNW_004955561:1,277,362...1,282,949
Ensembl chrNW_004955561:1,277,365...1,282,793
|
|
G |
Phlda1 |
pleckstrin homology like domain family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955405:15,318,785...15,321,316
Ensembl chrNW_004955405:15,320,005...15,321,301
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955437:5,940,825...5,945,367
Ensembl chrNW_004955437:5,942,106...5,945,431
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955536:730,962...754,333
Ensembl chrNW_004955536:730,981...756,394
|
|
G |
Prdx4 |
peroxiredoxin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955509:4,111,501...4,132,529
Ensembl chrNW_004955509:4,116,379...4,132,529
|
|
G |
Qpct |
glutaminyl-peptide cyclotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955441:5,138,477...5,168,056
Ensembl chrNW_004955441:5,138,477...5,168,455
|
|
G |
Rab32 |
RAB32, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955436:14,171,123...14,177,255
Ensembl chrNW_004955436:14,171,123...14,177,577
|
|
G |
Rgs1 |
regulator of G protein signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955406:30,042,354...30,047,172
Ensembl chrNW_004955406:30,041,870...30,047,752
|
|
G |
Sat1 |
spermidine/spermine N1-acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955509:4,198,876...4,202,103
Ensembl chrNW_004955509:4,198,651...4,202,483
|
|
G |
Sele |
selectin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17597826 |
|
NCBI chrNW_004955462:7,564,437...7,575,297
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17374397 |
|
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955442:7,321,337...7,323,109
Ensembl chrNW_004955442:7,321,337...7,323,109
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955405:30,349,956...30,623,849
Ensembl chrNW_004955405:30,366,866...30,375,468 Ensembl chrNW_004955405:30,366,866...30,375,468
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14555839 |
|
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
|
|
G |
St6gal1 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955420:20,708,890...20,801,167
Ensembl chrNW_004955420:20,709,301...20,801,167
|
|
G |
Stac |
SH3 and cysteine rich domain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955421:3,325,199...3,471,748
Ensembl chrNW_004955421:3,325,199...3,471,742
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility |
ISO |
|
RGD |
PMID:9303338 |
RGD:6482276 |
NCBI chrNW_004955437:1,480,217...1,499,032
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:18725520 PMID:20711192 |
RGD:7777133 RGD:7794737 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tlr7 |
toll like receptor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955544:424,897...443,562
Ensembl chrNW_004955544:424,850...443,564
|
|
G |
Tmsb10 |
thymosin beta 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17597826 |
|
NCBI chrNW_004955424:2,471,845...2,472,515
Ensembl chrNW_004955424:2,472,105...2,472,499
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15849067 |
|
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 PMID:17374397 |
|
NCBI chrNW_004955440:16,915,952...16,944,375
Ensembl chrNW_004955440:16,916,055...16,944,190
|
|
G |
Tslp |
thymic stromal lymphopoietin |
treatment |
ISO |
|
RGD |
PMID:30187507 |
RGD:38596345 |
NCBI chrNW_004955418:4,041,529...4,045,534
|
|
G |
Upp1 |
uridine phosphorylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16033404 |
|
NCBI chrNW_004955456:5,365,912...5,385,336
Ensembl chrNW_004955456:5,365,877...5,385,336
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
mRNA:protein:skin: |
RGD |
PMID:7876550 |
RGD:7421586 |
NCBI chrNW_004955437:9,527,445...9,541,908
|
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
associated with Severe Congenital Neutropenia; |
RGD |
PMID:20100783 |
RGD:11039037 |
NCBI chrNW_004955451:14,688,181...14,690,126
Ensembl chrNW_004955451:14,688,181...14,690,126
|
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
severity |
ISO |
DNA:snp:exon:c.1236C>T (human) |
RGD |
PMID:24040855 |
RGD:8657076 |
NCBI chrNW_004955432:4,911,774...5,085,349
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (rat) |
RGD |
PMID:15362690 |
RGD:11522724 |
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29028686 |
|
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
|
ISO |
protein:increased expression:oronasal secretion (human) |
RGD |
PMID:23883806 |
RGD:7364793 |
NCBI chrNW_004955456:14,554,583...14,558,967
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
treatment |
ISO |
|
RGD |
PMID:10436391 |
RGD:11344920 |
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:21711961 |
RGD:5147783 |
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
|
|
G |
Hrh1 |
histamine receptor H1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23333628 |
|
NCBI chrNW_004955429:14,022,332...14,069,931
Ensembl chrNW_004955429:14,067,405...14,068,853
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
associated with Asthma |
RGD |
PMID:12787306 PMID:18510219 |
RGD:10755770 RGD:7829803 |
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:23253209 PMID:23883806 |
RGD:7364793 RGD:7364818 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il13 |
interleukin 13 |
susceptibility no_association |
ISO |
ClinVar Annotator: match by term: Allergic rhinitis DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) |
OMIM ClinVar RGD |
PMID:10699178 PMID:12928861 PMID:15356556 PMID:15483090 PMID:15711639 |
RGD:8549516 |
NCBI chrNW_004955408:4,046,406...4,049,795
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21462799 |
RGD:8549521 |
NCBI chrNW_004955490:708,144...758,195
Ensembl chrNW_004955490:709,446...758,272
|
|
G |
Il17a |
interleukin 17A |
susceptibility |
ISO |
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:21535180 PMID:22507625 |
RGD:5147409 RGD:9068429 |
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
|
|
G |
Il18 |
interleukin 18 |
no_association severity |
ISO |
DNA:SNP:promoter:-140C>G (rs360721) (human) DNA:SNP:promoter:-137G>C (rs187238) (human) |
RGD |
PMID:22840759 |
RGD:8655914 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7750009 |
RGD:7401199 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:12592663 |
RGD:8662963 |
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
|
RGD |
PMID:8908280 PMID:9893928 PMID:14653048 PMID:24620662 |
RGD:11522769 RGD:7829796 RGD:7829802 RGD:7829827 |
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Il5 |
interleukin 5 |
treatment |
ISO |
|
RGD |
PMID:23934070 PMID:24620662 |
RGD:11354976 RGD:11522769 |
NCBI chrNW_004955408:3,937,128...3,951,784
Ensembl chrNW_004955408:3,937,894...3,939,358
|
|
G |
Itgb2 |
integrin subunit beta 2 |
treatment |
ISO |
|
RGD |
PMID:12046991 |
RGD:9698435 |
NCBI chrNW_004955407:41,779,849...41,805,637
Ensembl chrNW_004955407:41,777,777...41,800,201
|
|
G |
Muc1 |
mucin 1, cell surface associated |
severity |
ISO |
mRNA,protein:decreased expression:nasal mucosa |
RGD |
PMID:31425778 |
RGD:127345100 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium |
RGD |
PMID:22972875 |
RGD:7364746 |
NCBI chrNW_004955476:11,061,405...11,084,294
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:23858718 |
RGD:8547523 |
NCBI chrNW_004955433:8,746,213...8,780,119
Ensembl chrNW_004955433:8,746,004...8,782,710
|
|
G |
Pon1 |
paraoxonase 1 |
severity |
ISO |
protein:decreased activity:plasma (human) |
RGD |
PMID:23406590 |
RGD:8547583 |
NCBI chrNW_004955432:11,893,473...11,923,035
Ensembl chrNW_004955432:11,893,473...11,923,339
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
|
ISO |
protein:increased expression:nasal cavity epithelium |
RGD |
PMID:24012634 |
RGD:7775060 |
NCBI chrNW_004955425:6,176,335...7,335,867
Ensembl chrNW_004955425:6,176,432...7,331,446
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16979129 |
|
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
|
ISO |
mRNA:decreased expression:nasal mucosa, lung |
RGD |
PMID:17882576 |
RGD:5144135 |
NCBI chrNW_004955599:688,414...690,644
|
|
G |
Scgb3a2 |
secretoglobin family 3A member 2 |
susceptibility |
ISO |
DNA:SNP: :rs7726552 (human) |
RGD |
PMID:21410962 |
RGD:5144225 |
NCBI chrNW_004955415:6,332,121...6,335,474
Ensembl chrNW_004955415:6,331,535...6,335,462
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
mRNA:increased expression:nasal mucosa (mouse) |
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:nasal mucosa |
RGD |
PMID:12768696 |
RGD:5147835 |
NCBI chrNW_004955424:10,614,340...10,761,872
Ensembl chrNW_004955424:10,614,340...10,761,872
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:31368266 |
RGD:14995445 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Tlr2 |
toll like receptor 2 |
severity |
ISO |
protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa: DNA:polymorphism:cds:p.R753Q(human) |
RGD |
PMID:18219831 PMID:18381801 PMID:22402138 PMID:22555057 |
RGD:7800732 RGD:7800742 RGD:8552972 RGD:8552993 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr4 |
toll like receptor 4 |
no_association severity treatment susceptibility |
ISO |
protein:decreased expression:nasal mucosa: DNA:polymorphism: :4216G>C(human) protein:increased expression:nasal lavage,leukocyte, bone marrow: DNA:polymorphism:cds:p.D299G(human) DNA:SNP: :rs1927911(human) |
RGD |
PMID:17069098 PMID:19763595 PMID:22402138 PMID:22555057 PMID:22577387 PMID:23639307 More...
|
RGD:4145354 RGD:7800732 RGD:7800736 RGD:7800738 RGD:7800740 RGD:8552993 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tlr9 |
toll like receptor 9 |
|
ISO |
protein:decreased expression:nasal mucosa: |
RGD |
PMID:22577387 |
RGD:7800740 |
NCBI chrNW_004955532:3,828,645...3,832,699
|
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
disease_progression |
ISO |
|
RGD |
PMID:20959119 |
RGD:6893644 |
NCBI chrNW_004955431:19,025,663...19,027,026
|
|
G |
Agt |
angiotensinogen |
|
ISO |
|
RGD |
PMID:1422942 |
RGD:8548893 |
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
|
|
G |
Aspg |
asparaginase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:65671 |
|
NCBI chrNW_004955538:2,765,215...2,785,390
Ensembl chrNW_004955538:2,765,104...2,785,526
|
|
G |
Btk |
Bruton tyrosine kinase |
treatment |
ISO |
|
RGD |
PMID:22228807 |
RGD:11040701 |
NCBI chrNW_004955503:7,483,819...7,515,085
Ensembl chrNW_004955503:7,482,793...7,515,120
|
|
G |
Cabs1 |
calcium binding protein, spermatid associated 1 |
treatment |
ISO |
|
RGD |
PMID:25632019 |
RGD:14400306 |
NCBI chrNW_004955447:2,581,173...2,582,481
|
|
G |
Grap2 |
GRB2 related adaptor protein 2 |
ameliorates |
ISO |
|
RGD |
PMID:18664516 |
RGD:126790488 |
NCBI chrNW_004955413:25,691,824...25,758,461
Ensembl chrNW_004955413:25,691,439...25,758,813
|
|
G |
Hdac3 |
histone deacetylase 3 |
|
ISO |
|
RGD |
PMID:24619412 |
RGD:9590165 |
NCBI chrNW_004955415:12,138,520...12,154,234
Ensembl chrNW_004955415:12,138,870...12,154,234
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
associated with cystic echinococcosis; protein:increased expression:blood mRNA:increased expression:lung, intestine, spleen |
RGD |
PMID:24468678 PMID:28095662 |
RGD:10402796 RGD:14696684 |
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7623993 |
|
NCBI chrNW_004955420:20,989,197...21,016,084
|
|
G |
Ltb4r |
leukotriene B4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10934231 |
|
NCBI chrNW_004955409:35,984,757...35,991,492
Ensembl chrNW_004955409:35,984,933...35,985,976
|
|
G |
Nlrp3 |
NLR family pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19767079 |
|
NCBI chrNW_004955581:597,952...616,903
Ensembl chrNW_004955581:597,667...617,410
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
|
RGD |
PMID:18480553 |
RGD:2300247 |
NCBI chrNW_004955419:5,678,750...5,699,305
Ensembl chrNW_004955419:5,678,694...5,699,305
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:17822719 PMID:18480553 |
RGD:1642600 RGD:2300247 |
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:21604443 |
RGD:7207802 |
NCBI chrNW_004955435:5,390,745...5,410,025
Ensembl chrNW_004955435:5,390,751...5,411,691
|
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8458210 |
|
NCBI chrNW_004955447:9,327...21,212
|
|
G |
F12 |
coagulation factor XII |
|
ISO |
ClinVar Annotator: match by term: Angioedema |
ClinVar |
PMID:16638441 PMID:25741868 |
|
NCBI chrNW_004955408:29,644,279...29,665,161
Ensembl chrNW_004955408:29,642,096...29,650,950
|
|
G |
LOC102026469 |
HLA class II histocompatibility antigen, DP beta 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15784113 |
|
NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16184341 PMID:18453163 PMID:20547619 |
|
NCBI chrNW_004955536:730,962...754,333
Ensembl chrNW_004955536:730,981...756,394
|
|
G |
Serping1 |
serpin family G member 1 |
susceptibility |
ISO |
DNA:mutations:exon ClinVar Annotator: match by term: Angioedema |
RGD ClinVar |
PMID:12402344 |
RGD:1600545 |
NCBI chrNW_004955511:2,545,337...2,557,850
Ensembl chrNW_004955511:2,545,285...2,557,982
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
ClinVar Annotator: match by term: Angioedema |
ClinVar |
PMID:16638441 PMID:25741868 |
|
NCBI chrNW_004955408:29,626,775...29,640,811
Ensembl chrNW_004955408:29,626,775...29,640,875
|
|
G |
Sytl2 |
synaptotagmin like 2 |
|
ISO |
ClinVar Annotator: match by term: Angioedema |
ClinVar |
PMID:28327206 |
|
NCBI chrNW_004955414:7,104,239...7,172,791
Ensembl chrNW_004955414:7,104,268...7,174,001
|
|
G |
Xpnpep2 |
X-prolyl aminopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16175507 |
|
NCBI chrNW_004955473:5,248,065...5,274,469
Ensembl chrNW_004955473:5,245,746...5,274,698
|
|
|
G |
Btk |
Bruton tyrosine kinase |
treatment |
ISO |
|
RGD |
PMID:22228807 |
RGD:11040701 |
NCBI chrNW_004955503:7,483,819...7,515,085
Ensembl chrNW_004955503:7,482,793...7,515,120
|
|
G |
Cfd |
complement factor D |
|
ISO |
|
RGD |
PMID:10605043 |
RGD:1624328 |
NCBI chrNW_004955495:6,955,612...6,961,317
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:23470165 |
RGD:9068463 |
NCBI chrNW_004955427:24,691,206...24,705,599
Ensembl chrNW_004955427:24,701,073...24,707,230
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
DNA:SNP:promoter:-374T>A (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
associated with Neutropenia;mRNA:increased expression:lung |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chrNW_004955472:1,444,598...1,446,488
Ensembl chrNW_004955472:1,444,316...1,446,490
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
associated with Neutropenia |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chrNW_004955451:15,086,119...15,101,862
Ensembl chrNW_004955451:15,086,119...15,095,561
|
|
G |
Cftr |
CF transmembrane conductance regulator |
severity |
ISO |
|
RGD |
PMID:22135344 |
RGD:35673332 |
NCBI chrNW_004955432:23,179,645...23,328,347
Ensembl chrNW_004955432:23,178,866...23,328,382
|
|
G |
Clec1a |
C-type lectin domain family 1 member A |
susceptibility |
ISO |
ClinVar Annotator: match by term: Aspergillosis, susceptibility to |
OMIM ClinVar |
PMID:29489751 |
|
NCBI chrNW_004955413:7,742,753...7,783,299
Ensembl chrNW_004955413:7,752,111...7,782,452
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16893395 |
RGD:4981337 |
NCBI chrNW_004955471:1,496,352...1,583,919
Ensembl chrNW_004955471:1,497,483...1,511,469
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
DNA:SNP: :427C>T (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chrNW_004955407:42,972,584...42,980,510
Ensembl chrNW_004955407:42,972,584...42,980,510
|
|
G |
Tlr1 |
toll like receptor 1 |
susceptibility |
ISO |
DNA:SNPs: :p.R80T, p.N248S (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chrNW_004955443:8,442,419...8,450,318
Ensembl chrNW_004955443:8,447,956...8,450,382
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19781388 |
RGD:4145322 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr6 |
toll like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chrNW_004955443:8,401,461...8,427,175
Ensembl chrNW_004955443:8,422,534...8,424,942
|
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
susceptibility |
ISO |
DNA:SNP,haplotype:rs192808(human) |
RGD |
PMID:20860846 |
RGD:13524562 |
NCBI chrNW_004955604:189,261...205,058
Ensembl chrNW_004955604:185,430...205,088
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20022477 PMID:20485159 |
RGD:4145619 |
NCBI chrNW_004955420:25,702,917...25,723,269
Ensembl chrNW_004955420:25,701,407...25,723,353
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:17641958 PMID:20485159 |
|
NCBI chrNW_004955557:1,667,518...1,702,272
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) |
CTD RGD |
PMID:15970796 PMID:16502481 PMID:20485159 |
RGD:5144000 |
NCBI chrNW_004955431:2,203,342...2,282,635
Ensembl chrNW_004955431:2,263,698...2,282,635
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
DNA:haplotype::rs4647416(human) |
RGD |
PMID:21670957 |
RGD:11045795 |
NCBI chrNW_004955422:22,031,825...22,246,478
Ensembl chrNW_004955422:22,032,258...22,247,044
|
|
G |
Il4 |
interleukin 4 |
susceptibility |
ISO |
DNA:SNPs:promoter,5'UTR,intron:multiple |
RGD |
PMID:20921925 |
RGD:11528633 |
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
LOC102026469 |
HLA class II histocompatibility antigen, DP beta 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 |
|
NCBI chrNW_004955408:788,856...791,505
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004955511:4,377,894...4,400,797
Ensembl chrNW_004955511:4,380,502...4,400,852
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chrNW_004955431:8,510,646...8,544,901
Ensembl chrNW_004955431:8,510,624...8,544,971
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004955511:5,536,602...5,539,944
Ensembl chrNW_004955511:5,536,642...5,537,926
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15496426 |
|
NCBI chrNW_004955409:10,760,801...10,775,197
Ensembl chrNW_004955409:10,757,888...10,774,688
|
|
G |
Ptgir |
prostaglandin I2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004955574:686,156...690,126
Ensembl chrNW_004955574:687,583...689,750
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9487340 PMID:16502481 PMID:20485159 |
RGD:5143936 |
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
|
RGD |
PMID:21796142 |
RGD:5147839 |
NCBI chrNW_004955437:1,480,217...1,499,032
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15806396 |
|
NCBI chrNW_004955451:13,315,237...13,317,888
Ensembl chrNW_004955451:13,315,859...13,325,937
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility |
ISO |
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15898979 PMID:16502481 PMID:20485159 |
RGD:11059537 |
NCBI chrNW_004955495:5,539,382...5,557,441
Ensembl chrNW_004955495:5,539,889...5,557,441
|
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
protein:increased expression:blood, lymphocyte |
RGD |
PMID:19484671 |
RGD:4890020 |
NCBI chrNW_004955432:4,911,774...5,085,349
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
|
RGD |
PMID:18931056 |
RGD:5128825 |
NCBI chrNW_004955442:729,322...858,826
Ensembl chrNW_004955442:729,316...860,290
|
|
G |
Acsl3 |
acyl-CoA synthetase long chain family member 3 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:19221603 |
RGD:13831295 |
NCBI chrNW_004955453:10,916,423...10,963,986
Ensembl chrNW_004955453:10,913,786...10,947,963
|
|
G |
Ada |
adenosine deaminase |
susceptibility |
ISO |
DNA:polymorphisms (human) |
RGD |
PMID:16754522 |
RGD:5128848 |
NCBI chrNW_004955445:12,696,096...12,717,488
Ensembl chrNW_004955445:12,696,096...12,717,488
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
susceptibility no_association disease_progression |
ISO |
DNA:polymorphism: :p.M764T (human) DNA:SNPs:introns,exon:7575G>A, 11188A>T, 12433T>C (human) mRNA:increased expression:bronchus DNA:SNPs (human) mRNA:increased expression:lung DNA:SNPs: :multiple (human) |
RGD |
PMID:16893396 PMID:17339047 PMID:17961406 PMID:18778489 PMID:19635592 PMID:19940503 More...
|
RGD:4145359 RGD:4145360 RGD:4145378 RGD:4145379 RGD:4145380 RGD:4145382 |
NCBI chrNW_004955415:14,523,517...14,535,701
Ensembl chrNW_004955415:14,524,354...14,533,700
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
severity |
ISO |
mRNA:increased expression:bronchus mRNA:increased expression:respiratory tract |
RGD |
PMID:17339047 PMID:19373511 PMID:20194813 |
RGD:4145380 RGD:5128872 RGD:5128878 |
NCBI chrNW_004955477:10,894,288...10,906,961
Ensembl chrNW_004955477:10,895,446...10,907,215
|
|
G |
Adcy2 |
adenylate cyclase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004955504:4,990,634...5,376,990
Ensembl chrNW_004955504:5,004,903...5,376,328
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21059121 |
|
NCBI chrNW_004955410:32,176,683...32,229,187
Ensembl chrNW_004955410:32,176,536...32,229,431
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
|
RGD |
PMID:19168697 |
RGD:5686821 |
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
protein:increased expression:bronchus DNA:SNPs: :1405C>T (human) |
RGD |
PMID:17959644 PMID:19019667 PMID:20400685 |
RGD:4145444 RGD:4890386 RGD:5129097 |
NCBI chrNW_004955406:39,148,811...39,183,577
Ensembl chrNW_004955406:39,149,689...39,187,688
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
DNA:SNP (human) mRNA:decreased expression:aorta |
RGD |
PMID:16339780 PMID:17293374 PMID:18310516 PMID:19019667 |
RGD:4890366 RGD:4890380 RGD:4890385 RGD:4890386 |
NCBI chrNW_004955455:7,886,720...7,906,214
Ensembl chrNW_004955455:7,895,974...7,906,505
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Beta-2-adrenoreceptor agonist, reduced response to |
OMIM ClinVar |
PMID:8383511 PMID:15284533 PMID:16596417 |
|
NCBI chrNW_004955415:5,515,157...5,517,198
Ensembl chrNW_004955415:5,515,697...5,516,980
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
treatment onset |
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased expression:lung (rat) |
RGD CTD |
PMID:21920897 PMID:23304218 PMID:33075463 |
RGD:6767554 RGD:7244279 |
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
|
ISO |
|
RGD |
PMID:19080339 |
RGD:5147457 |
NCBI chrNW_004955474:8,733,942...8,781,305
Ensembl chrNW_004955474:8,733,942...8,781,255
|
|
G |
Agtr2 |
angiotensin II receptor type 2 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19080339 |
RGD:5147457 |
NCBI chrNW_004955534:3,653,112...3,654,248
Ensembl chrNW_004955534:3,653,157...3,654,248
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9600491 PMID:11506308 |
|
NCBI chrNW_004955482:8,352,569...8,383,097
Ensembl chrNW_004955482:8,352,569...8,384,899
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:18692885 PMID:19628725 |
RGD:5509605 RGD:5509784 |
NCBI chrNW_004955467:10,032,792...10,039,789
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
susceptibility treatment severity no_association |
ISO |
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism protein:increased expression:lung DNA:polymorphism:promoter (human) DNA:polymorphism:cds:p.E254K (human) mRNA:increased expression:blood, leukocyte |
OMIM RGD CTD |
PMID:8879219 PMID:9642160 PMID:10369259 PMID:11035107 PMID:12911785 PMID:16364163 PMID:17394438 PMID:18204779 PMID:19033731 PMID:20128419 More...
|
RGD:4890407 RGD:4890408 RGD:4890410 RGD:4890413 RGD:4890415 RGD:4890422 RGD:5147462 RGD:5147465 RGD:5147467 RGD:734557 |
NCBI chrNW_004955546:2,495,226...2,550,909
Ensembl chrNW_004955546:2,494,819...2,550,909
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
no_association susceptibility |
ISO |
DNA:polymorphisms:intron:IVS2+12C>A, IVS2+105T>C (human) DNA:SNP: :rs10507391 (human) DNA:repeat:promoter:-169(A)21 (human) mRNA:increased expression:blood, leukocyte DNA:substitution, repeat:promoter:-336G>A, -169(A)19-23 (human) DNA:SNPs (human) protein:increased expression:lung DNA:polymorphism:promoter (human) |
RGD |
PMID:8879219 PMID:9642160 PMID:10527888 PMID:11035107 PMID:12911785 PMID:15784112 PMID:18547289 PMID:20067482 PMID:20128419 More...
|
RGD:4890405 RGD:4890407 RGD:4890409 RGD:4890422 RGD:5147462 RGD:5147464 RGD:5147465 RGD:5147466 RGD:5147467 |
NCBI chrNW_004955431:15,071,535...15,097,496
Ensembl chrNW_004955431:15,069,089...15,097,580
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:14621078 |
RGD:6904149 |
NCBI chrNW_004955419:13,478,904...13,492,329
Ensembl chrNW_004955419:13,478,552...13,492,327
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:22092555 |
RGD:7421657 |
NCBI chrNW_004955512:5,686,508...5,703,645
|
|
G |
Areg |
amphiregulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15696081 |
|
NCBI chrNW_004955474:680,212...689,021
Ensembl chrNW_004955474:680,204...689,088
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:lung, mononuclear cell (human) mRNA:increased expression:lung (mouse) DNA:SNP: :rs2781667 (human) |
CTD RGD |
PMID:12813022 PMID:19281908 PMID:19800904 PMID:20124949 |
RGD:4143187 RGD:5129205 |
NCBI chrNW_004955436:12,235,767...12,247,817
Ensembl chrNW_004955436:12,235,767...12,251,972
|
|
G |
Arg2 |
arginase 2 |
susceptibility severity |
ISO |
mRNA:increased expression:lung (mouse) CTD Direct Evidence: marker/mechanism DNA:SNPs (human) DNA:SNP: :rs3742879, rs17249437 (human) |
RGD CTD |
PMID:12813022 PMID:16387594 PMID:19281908 PMID:20124949 |
RGD:4143187 RGD:5129205 RGD:5129207 |
NCBI chrNW_004955466:2,549,557...2,577,060
Ensembl chrNW_004955466:2,549,557...2,577,060
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18357729 |
|
NCBI chrNW_004955402:46,911,125...47,084,214
Ensembl chrNW_004955402:46,916,266...47,084,485
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
onset |
ISO |
DNA:polymorphism:exon (human) protein:increased expression:blood, eosinophil |
RGD |
PMID:8856156 PMID:11517947 PMID:14727005 PMID:19038786 |
RGD:4890454 RGD:4890456 RGD:4891028 RGD:4891042 |
NCBI chrNW_004955438:16,514,300...16,537,160
Ensembl chrNW_004955438:16,511,759...16,537,172
|
|
G |
Bdnf |
brain derived neurotrophic factor |
susceptibility severity |
ISO |
DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) protein:decreased expression:blood, eosinophil DNA:polymorphisms: :p.V66M, -270C>T (human) protein:increased expression:plasma DNA:polymorphisms: :p.V66M (rs6265) (human) |
RGD |
PMID:11737043 PMID:12752594 PMID:17584309 PMID:19895626 PMID:20874832 PMID:21723144 More...
|
RGD:4891063 RGD:4891067 RGD:4891117 RGD:4891122 RGD:4891123 RGD:8655967 |
NCBI chrNW_004955476:6,773,244...6,822,201
Ensembl chrNW_004955476:6,772,088...6,822,588
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8429434 |
|
NCBI chrNW_004955545:2,381,091...2,382,114
Ensembl chrNW_004955545:2,381,156...2,381,978
|
|
G |
Bmpr1b |
bone morphogenetic protein receptor type 1B |
|
ISO |
protein:decreased expression:bronchus |
RGD |
PMID:18292470 |
RGD:5129470 |
NCBI chrNW_004955405:5,408,171...5,784,930
Ensembl chrNW_004955405:5,700,162...5,787,957
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
ISO |
protein:decreased expression:bronchus |
RGD |
PMID:18292470 |
RGD:5129470 |
NCBI chrNW_004955457:12,235,780...12,315,680
Ensembl chrNW_004955457:12,235,780...12,316,727
|
|
G |
C3 |
complement C3 |
severity |
ISO |
protein:increased expression:serum Interaction with IL4RA protein:increased expression:respiratory system fluid/secretion DNA:SNP: :4896C>T (human) DNA:SNPs: :multiple (human) DNA:SNP:intron:rs11569562 (human) |
RGD |
PMID:11591733 PMID:15278436 PMID:16355111 PMID:18566738 PMID:20395963 PMID:20402389 PMID:20589464 PMID:20802484 More...
|
RGD:5129501 RGD:5129505 RGD:5129512 RGD:5129517 RGD:5129519 RGD:5129537 RGD:5129538 RGD:5129681 |
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
|
|
G |
C3ar1 |
complement C3a receptor 1 |
severity |
ISO |
mRNA:increased expression:lung protein:increased expression:lung, leukocyte |
RGD |
PMID:15278436 PMID:15940127 PMID:17544263 PMID:20045013 PMID:20802484 |
RGD:5129512 RGD:5129560 RGD:5129561 RGD:5129681 RGD:5129686 |
NCBI chrNW_004955413:6,707,003...6,715,689
Ensembl chrNW_004955413:6,707,689...6,715,689
|
|
G |
C5ar1 |
complement C5a receptor 1 |
severity |
ISO |
protein:increased expression:lung, leukocyte protein:increased expression:respiratory tract |
RGD |
PMID:15940127 PMID:16511606 PMID:17544263 PMID:20802484 |
RGD:5129560 RGD:5129561 RGD:5129681 RGD:5130166 |
NCBI chrNW_004955574:1,221,942...1,229,634
Ensembl chrNW_004955574:1,221,187...1,231,655
|
|
G |
Card11 |
caspase recruitment domain family member 11 |
susceptibility |
ISO |
|
RGD |
PMID:16751370 |
RGD:11100037 |
NCBI chrNW_004955460:12,368,987...12,487,675
Ensembl chrNW_004955460:12,368,918...12,490,041
|
|
G |
Carm1 |
coactivator associated arginine methyltransferase 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004955495:1,983,599...2,002,174
Ensembl chrNW_004955495:1,983,599...2,002,174
|
|
G |
Cat |
catalase |
severity |
ISO |
protein:increased expression:erythrocyte protein:decreased activity:respiratory system fluid/secretion DNA:polymorphism:promoter:-262C>T (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-21A>T (human) |
RGD CTD |
PMID:16622028 PMID:18048809 PMID:19373626 PMID:19475625 |
RGD:5130751 RGD:5130753 RGD:5130856 RGD:5130867 |
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20455898 |
RGD:4891420 |
NCBI chrNW_004955481:9,085,943...9,089,147
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion mRNA:increased expression:lung |
RGD |
PMID:11160256 PMID:15947487 PMID:15993846 PMID:20074456 PMID:20237293 |
RGD:2306304 RGD:4145486 RGD:4145487 RGD:4145513 RGD:4145603 |
NCBI chrNW_004955433:15,052,616...15,054,732
Ensembl chrNW_004955433:15,053,061...15,054,572
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
protein:increased expression:bronchus submucosa, mast cell |
RGD |
PMID:16959919 |
RGD:5130911 |
NCBI chrNW_004955472:1,444,598...1,446,488
Ensembl chrNW_004955472:1,444,316...1,446,490
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion associated with Allergic Rhinitis;protein:increased expression:serum |
RGD |
PMID:18422729 PMID:22469443 |
RGD:7483597 RGD:7483618 |
NCBI chrNW_004955453:6,846,625...6,850,007
Ensembl chrNW_004955453:6,846,549...6,850,031
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion mRNA:increased expression:lung mRNA, protein:increased expression:respiratory system mucosa, respiratory system fluid/secretion |
RGD |
PMID:10384142 PMID:15993846 PMID:18316417 PMID:18684970 |
RGD:2306304 RGD:4145489 RGD:4891474 RGD:4891475 |
NCBI chrNW_004955433:15,002,001...15,007,324
Ensembl chrNW_004955433:15,001,930...15,008,032
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
susceptibility |
ISO |
protein:increased expression:respiratory system fluid/secretion DNA:SNPs: :304C>A, 1272A>G (human) DNA:SNP: :1265A>G (human) protein:increased expression:plasma DNA:SNPs: :179T>C, 275C>T (human) |
RGD |
PMID:12761043 PMID:12952266 PMID:15207712 PMID:16304252 PMID:17060636 PMID:17548626 PMID:18712274 More...
|
RGD:4891483 RGD:4891484 RGD:4891485 RGD:4891495 RGD:4891496 RGD:5130930 RGD:5130932 |
NCBI chrNW_004955456:14,582,812...14,588,574
Ensembl chrNW_004955456:14,583,610...14,585,169
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
treatment |
ISO |
DNA:SNPs: :77C>T, 716A>G, 1579G>A (human) protein:increased expression:plasma DNA:SNPs: :77C>T, 2497T>G (human) |
RGD |
PMID:15207712 PMID:16304252 PMID:18712274 PMID:25399816 PMID:25530546 |
RGD:11081163 RGD:11087575 RGD:4891483 RGD:4891495 RGD:5130930 |
NCBI chrNW_004955456:14,554,583...14,558,967
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
|
ISO |
|
RGD |
PMID:19541356 |
RGD:5130899 |
NCBI chrNW_004955472:1,470,407...1,474,800
Ensembl chrNW_004955472:1,471,551...1,474,777
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16290206 |
RGD:4892195 |
NCBI chrNW_004955446:18,902,465...18,925,178
Ensembl chrNW_004955446:18,902,636...18,925,561
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
protein:increased expression:lung, secretion (mouse) CTD Direct Evidence: marker/mechanism protein:increased expression:smooth muscle cell DNA:transition:5' utr:-403G>A (human) |
RGD CTD |
PMID:8534483 PMID:18208670 PMID:20092989 PMID:20430255 |
RGD:2307112 RGD:4891381 RGD:4891430 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
susceptibility |
ISO |
protein:increased expression:lung, dendritic cell (mouse) DNA:haplotype:cds:p.V64I(human) DNA:SNP:cds:p.V64I (human) |
RGD |
PMID:17298432 PMID:19917684 PMID:23454776 |
RGD:4145110 RGD:8549811 RGD:8551842 |
NCBI chrNW_004955420:25,641,184...25,664,413
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, neutrophil DNA:SNP:exon:51T>C (human) |
RGD |
PMID:16978084 PMID:17145927 PMID:18699933 PMID:19017998 PMID:19657453 PMID:20134116 PMID:20220260 More...
|
RGD:1601020 RGD:4145618 RGD:4145623 RGD:4145632 RGD:4145633 RGD:4145638 RGD:4145646 |
NCBI chrNW_004955420:25,702,917...25,723,269
Ensembl chrNW_004955420:25,701,407...25,723,353
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chrNW_004955421:205,297...210,944
Ensembl chrNW_004955421:205,297...210,944
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
|
ISO |
protein:increased expression:lung, dendritic cell (mouse) |
RGD |
PMID:19917684 |
RGD:8549811 |
NCBI chrNW_004955439:14,921,524...14,949,493
Ensembl chrNW_004955439:14,920,601...14,924,191
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
protein:increased expression:lung, dendritic cell (mouse) |
RGD |
PMID:19917684 |
RGD:8549811 |
NCBI chrNW_004955451:15,086,119...15,101,862
Ensembl chrNW_004955451:15,086,119...15,095,561
|
|
G |
Ccr8 |
C-C motif chemokine receptor 8 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chrNW_004955427:24,646,358...24,690,580
Ensembl chrNW_004955427:24,644,479...24,691,132
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
|
ISO |
mRNA, protein:increased expression:blood, mature NK T cell |
RGD |
PMID:16210593 |
RGD:5130925 |
NCBI chrNW_004955420:26,083,445...26,093,740
Ensembl chrNW_004955420:26,083,040...26,093,775
|
|
G |
Cd14 |
CD14 molecule |
severity no_association susceptibility |
ISO |
protein:increased expression:serum|DNA:polymorphism:promoter:c. -159C>T (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: : DNA:polymorphism:promoter:c. -260C>T (human) |
RGD CTD |
PMID:15741437 PMID:15940135 PMID:16387800 PMID:17607003 PMID:18312481 PMID:19096003 More...
|
RGD:4144208 RGD:4144228 RGD:4144813 RGD:4144814 RGD:4144815 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
Cd274 |
CD274 molecule |
treatment |
ISO |
associated with Chlamydia pneumonia |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chrNW_004955434:9,487,309...9,508,366
Ensembl chrNW_004955434:9,487,315...9,505,904
|
|
G |
Cd28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:21356099 |
RGD:5131612 |
NCBI chrNW_004955457:11,159,769...11,253,099
Ensembl chrNW_004955457:11,162,282...11,192,991
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:19159017 PMID:19220210 PMID:20205594 PMID:20941750 |
RGD:4144188 RGD:4892277 RGD:5132272 RGD:8547792 |
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
|
|
G |
Cd40lg |
CD40 ligand |
severity |
ISO |
|
RGD |
PMID:9502776 |
RGD:11352238 |
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:21051864 PMID:21352203 PMID:21440530 |
RGD:5132619 RGD:5132620 RGD:5132621 |
NCBI chrNW_004955427:19,237,251...19,274,001
Ensembl chrNW_004955427:19,236,445...19,261,517
|
|
G |
Cd86 |
CD86 molecule |
treatment |
ISO |
protein:increased expression:blood, B cell (human) protein:increased expression:lung, dendritic cell (rat) DNA:snp:exon:p.I179V rs2681417 (human) protein:increased expression:lung, alveolar macrophage (mouse) |
RGD |
PMID:9449507 PMID:9551945 PMID:17513529 PMID:20668438 PMID:20941750 PMID:25344652 More...
|
RGD:11354965 RGD:4892199 RGD:4892202 RGD:4892277 RGD:4892280 RGD:4892555 |
NCBI chrNW_004955427:21,375,820...21,436,767
Ensembl chrNW_004955427:21,375,794...21,435,874
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
|
RGD |
PMID:21540309 |
RGD:5132878 |
NCBI chrNW_004955484:7,782,409...7,861,082
Ensembl chrNW_004955484:7,782,772...7,860,967
|
|
G |
Cdhr3 |
cadherin related family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241537 |
|
NCBI chrNW_004955410:10,457,078...10,520,429
Ensembl chrNW_004955410:10,457,072...10,519,826
|
|
G |
Cftr |
CF transmembrane conductance regulator |
susceptibility |
ISO |
DNA:deletion: :p.F508del(human) |
RGD |
PMID:20298391 |
RGD:4140387 |
NCBI chrNW_004955432:23,179,645...23,328,347
Ensembl chrNW_004955432:23,178,866...23,328,382
|
|
G |
Chat |
choline O-acetyltransferase |
|
ISO |
Protein:decreased expression:lung epithelium |
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004955556:650,290...695,135
Ensembl chrNW_004955556:650,279...693,276
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 7 |
OMIM ClinVar |
PMID:18403759 |
|
NCBI chrNW_004955406:39,195,101...39,201,808
Ensembl chrNW_004955406:39,191,073...39,202,020
|
|
G |
Chml |
CHM like Rab escort protein |
|
ISO |
|
RGD |
PMID:18343558 |
RGD:5133238 |
NCBI chrNW_004955406:10,455,367...10,461,934
|
|
G |
Chrm1 |
cholinergic receptor muscarinic 1 |
|
ISO |
|
RGD |
PMID:16931638 |
RGD:5133416 |
NCBI chrNW_004955599:349,744...356,714
Ensembl chrNW_004955599:349,744...356,714
|
|
G |
Chrm2 |
cholinergic receptor muscarinic 2 |
|
ISO |
DNA:SNP: :rs6962027 (human) |
RGD |
PMID:19308904 |
RGD:5509586 |
NCBI chrNW_004955494:5,845,581...5,975,614
Ensembl chrNW_004955494:5,847,156...5,848,556
|
|
G |
Chrm3 |
cholinergic receptor muscarinic 3 |
severity |
ISO |
|
RGD |
PMID:18348887 PMID:20394512 |
RGD:5133437 RGD:5133438 |
NCBI chrNW_004955492:958,347...1,429,832
Ensembl chrNW_004955492:958,949...960,721
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:21496385 |
RGD:5133703 |
NCBI chrNW_004955507:6,066,026...6,102,066
Ensembl chrNW_004955507:6,067,203...6,102,001
|
|
G |
Clca1 |
chloride channel accessory 1 |
susceptibility |
ISO |
DNA:SNPs (human) |
RGD |
PMID:11296262 PMID:15318163 PMID:17898169 |
RGD:4145653 RGD:4145656 RGD:4145661 |
NCBI chrNW_004955423:7,684,741...7,714,438
Ensembl chrNW_004955423:7,684,709...7,714,449
|
|
G |
Cldn18 |
claudin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27215490 |
|
NCBI chrNW_004955501:962,188...991,922
Ensembl chrNW_004955501:962,188...991,922
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
DNA:SNP: :RS242941 (human) DNA:SNPs: :rs1876828, rs242939, rs242941 (human) |
RGD |
PMID:16113459 PMID:19663668 |
RGD:5147485 RGD:5147488 |
NCBI chrNW_004955478:10,380,185...10,390,838
Ensembl chrNW_004955478:10,379,287...10,404,825
|
|
G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:18408560 |
RGD:5130938 |
NCBI chrNW_004955410:31,830,333...31,874,384
Ensembl chrNW_004955410:31,828,506...31,875,100
|
|
G |
Csf2 |
colony stimulating factor 2 |
severity |
ISO |
protein:increased expression:lung protein:increased expression:sputum |
RGD |
PMID:9717963 PMID:19213775 PMID:20405019 |
RGD:10449521 RGD:5131473 RGD:5131476 |
NCBI chrNW_004955408:3,452,009...3,454,255
Ensembl chrNW_004955408:3,451,965...3,454,312
|
|
G |
Csf2rb |
colony stimulating factor 2 receptor beta common subunit |
|
ISO |
|
RGD |
PMID:17145927 |
RGD:1601020 |
NCBI chrNW_004955413:23,442,417...23,465,093
Ensembl chrNW_004955413:23,449,111...23,463,820
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20405019 PMID:21396376 |
RGD:5131473 RGD:5133731 |
NCBI chrNW_004955451:14,688,181...14,690,126
Ensembl chrNW_004955451:14,688,181...14,690,126
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
no_association severity treatment |
ISO |
DNA:SNPs:promoter, exon:-1147C>T, -318C>T, 49A>G (human) protein:increased expression:serum DNA:SNPs: :multiple (human) DNA:polymorphisms:promoter, exon:-318C>T 49A>G (human) DNA:SNP: :rs3087243 (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-318C>T (human) |
RGD CTD |
PMID:11726402 PMID:12114354 PMID:12956753 PMID:15316504 PMID:15871446 PMID:16677453 PMID:16708626 PMID:16926542 PMID:17237396 PMID:17469155 PMID:18699801 PMID:19895365 PMID:28807506 More...
|
RGD:11344922 RGD:4891510 RGD:4891514 RGD:4891516 RGD:4891517 RGD:4891519 RGD:4891521 RGD:4891522 RGD:4891526 RGD:4891527 RGD:4891528 RGD:4891529 |
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
|
|
G |
Ctnna3 |
catenin alpha 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19187332 |
|
NCBI chrNW_004955425:18,623,645...20,126,200
Ensembl chrNW_004955425:18,628,961...20,087,647
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:14657873 |
RGD:4891906 |
NCBI chrNW_004955433:15,023,272...15,034,650
Ensembl chrNW_004955433:15,023,050...15,034,711
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
no_association |
ISO |
DNA:SNPs: :p.V249I, rs2669849 (human) DNA:polymorphisms: :p.V249I, p.T280M (human) |
RGD |
PMID:17082760 PMID:17505143 PMID:21037587 |
RGD:4891882 RGD:4891895 RGD:4891904 |
NCBI chrNW_004955427:24,691,206...24,705,599
Ensembl chrNW_004955427:24,701,073...24,707,230
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:11994485 PMID:16602032 PMID:17302903 |
RGD:5135439 RGD:5135452 RGD:5135457 |
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21150878 |
|
NCBI chrNW_004955408:30,733,079...30,740,854
Ensembl chrNW_004955408:30,733,079...30,740,854
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15210824 |
RGD:5135447 |
NCBI chrNW_004955433:724,566...731,945
Ensembl chrNW_004955433:724,515...732,192
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
severity susceptibility |
ISO |
protein:decreased expression:respiratory system fluid/secretion, T cell DNA:SNP:intron:IVS1+234G>A (human) |
RGD |
PMID:16043121 PMID:16548899 PMID:17641057 PMID:18094012 |
RGD:4892088 RGD:5135484 RGD:5143932 RGD:5143934 |
NCBI chrNW_004955475:11,148,928...11,152,313
Ensembl chrNW_004955475:11,148,879...11,152,596
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
severity no_association |
ISO |
DNA:SNPs:promoter:-634C>T, -475A>C, -336A>G (human) mRNA, protein:increased expression:respiratory system mucosa DNA:SNPs:promoter, exon:multiple (human) DNA:SNP: :927T>C (human) |
RGD |
PMID:8087328 PMID:11591188 PMID:16123393 PMID:16387808 PMID:16630147 PMID:16771777 PMID:16776674 PMID:17153879 PMID:17689528 More...
|
RGD:4781449 RGD:4781742 RGD:4782072 RGD:4784257 RGD:4843543 RGD:4847129 RGD:4848936 RGD:4888514 RGD:4889116 |
NCBI chrNW_004955557:1,667,518...1,702,272
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
DNA:polymorphism: :601A>G (human) DNA:polymorphism: :-1220A>C (human) |
RGD |
PMID:15454733 PMID:15475736 |
RGD:5144002 RGD:5144003 |
NCBI chrNW_004955431:2,203,342...2,282,635
Ensembl chrNW_004955431:2,263,698...2,282,635
|
|
G |
Dcn |
decorin |
|
ISO |
|
RGD |
PMID:16387756 |
RGD:2311423 |
NCBI chrNW_004955405:28,335,493...28,371,912
Ensembl chrNW_004955405:28,332,545...28,372,323
|
|
G |
Dnah5 |
dynein axonemal heavy chain 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004955426:3,105,631...3,406,587
Ensembl chrNW_004955426:3,106,410...3,353,502
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
DNA,mRNA:hypermethylation,decreased expression:promoter,respiratory tract: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23196709 PMID:23423710 |
RGD:9588646 |
NCBI chrNW_004955495:1,465,529...1,505,379
Ensembl chrNW_004955495:1,465,480...1,505,462
|
|
G |
Dpp10 |
dipeptidyl peptidase like 10 |
|
ISO |
DNA:SNP:exon (human) DNA:SNPs (human) protein:increased expression:bronchus DNA:SNP: :rs10208402 (human) |
RGD |
PMID:14566338 PMID:17967935 PMID:19672052 PMID:21103062 |
RGD:4889866 RGD:4892275 RGD:4892276 RGD:4892278 |
NCBI chrNW_004955459:13,456,765...14,767,495
Ensembl chrNW_004955459:13,453,491...14,109,194
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
|
ISO |
|
RGD |
PMID:21255010 |
RGD:5128488 |
NCBI chrNW_004955495:4,609,841...4,615,686
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
DNA:transition:intron:g.4124T>C (human) CTD Direct Evidence: marker/mechanism Severe Persistent Allergic Asthma; protein:increased secretion:lung (human) |
RGD CTD |
PMID:11668616 PMID:16981460 PMID:20588001 |
RGD:4144869 RGD:4144895 |
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
|
|
G |
Ednra |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:17448648 PMID:18632188 |
RGD:4892288 RGD:4892322 |
NCBI chrNW_004955428:3,062,303...3,114,761
Ensembl chrNW_004955428:3,062,303...3,114,761
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
mRNA:increased expression:bronchus, smooth muscle cell DNA:polymorphism (human) |
RGD |
PMID:15245576 PMID:17470272 PMID:18632188 |
RGD:4892288 RGD:4892321 RGD:4892324 |
NCBI chrNW_004955404:29,394,253...29,425,358
Ensembl chrNW_004955404:29,394,164...29,425,358
|
|
G |
Egfr |
epidermal growth factor receptor |
severity |
ISO |
protein:increased expression:lung epithelium (rat) protein:increased expression:bronchial epithelium (human) protein:increased expression:lung epithelium (mouse) |
RGD |
PMID:12580917 PMID:19954006 PMID:21072743 PMID:21224214 |
RGD:5131468 RGD:5131633 RGD:5131642 RGD:5131870 |
NCBI chrNW_004955456:321,222...456,431
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) mRNA:increased expression:bronchoalveolar lavage cell (human) |
RGD |
PMID:11254538 PMID:18507785 PMID:18774390 |
RGD:5130915 RGD:5131985 RGD:5131993 |
NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007
|
|
G |
Elp1 |
elongator acetyltransferase complex subunit 1 |
no_association |
ISO |
|
RGD |
PMID:11281413 PMID:12774215 |
RGD:5129157 RGD:5129158 |
NCBI chrNW_004955419:18,035,197...18,097,681
Ensembl chrNW_004955419:18,038,507...18,095,894
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
susceptibility |
ISO |
DNA:SNPs:exons:p.Y113H (rs1051740), p.H139R (rs2234922) (human) |
RGD |
PMID:17711870 |
RGD:4889407 |
NCBI chrNW_004955520:116,363...142,983
Ensembl chrNW_004955520:116,363...128,665
|
|
G |
Epx |
eosinophil peroxidase |
severity disease_progression |
ISO |
protein:increased activity:sputum,nasal,pharyngeal mucosa |
RGD |
PMID:12199967 PMID:20813885 PMID:26645423 |
RGD:11574908 RGD:13506891 RGD:13506892 |
NCBI chrNW_004955451:4,818,809...4,828,913
Ensembl chrNW_004955451:4,818,809...4,828,913
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
mRNA:decreased expression:lung (rat) |
RGD |
PMID:18375789 |
RGD:8694127 |
NCBI chrNW_004955466:5,587,003...5,644,765
Ensembl chrNW_004955466:5,575,088...5,638,946
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:plasma associated with Rhinosinusitis, associated with Nasal Polyps;protein:increased expression:nasal mucus |
RGD |
PMID:21658190 PMID:21711961 |
RGD:5147753 RGD:5147783 |
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:19864598 |
RGD:4892589 |
NCBI chrNW_004955425:24,050,901...24,054,039
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
|
RGD |
PMID:24523826 |
RGD:11040539 |
NCBI chrNW_004955404:685,170...692,797
Ensembl chrNW_004955404:680,594...693,665
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
mRNA:increased expression:eosinophil |
RGD |
PMID:16337971 |
RGD:1600350 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
severity |
ISO |
Asthma symptoms persistent despite steroids Fatal asthma subjects |
RGD |
PMID:20937062 PMID:21388666 |
RGD:5128711 RGD:5128717 |
NCBI chrNW_004955468:11,094,792...11,101,191
Ensembl chrNW_004955468:11,094,788...11,101,173
|
|
G |
Fcgr2b |
Fc fragment of IgG receptor IIb |
|
ISO |
|
RGD |
PMID:20179765 |
RGD:11344929 |
NCBI chrNW_004955462:14,639,396...14,653,801
|
|
G |
Fga |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24523826 |
RGD:11040539 |
NCBI chrNW_004955471:8,806,964...8,814,671
Ensembl chrNW_004955471:8,806,650...8,816,791
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
|
ISO |
ClinVar Annotator: match by term: Asthma |
ClinVar |
|
|
NCBI chrNW_004955437:3,445,515...3,548,874
Ensembl chrNW_004955437:3,447,075...3,548,564
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27633092 PMID:27965764 PMID:28944907 PMID:29317916 |
RGD:38548920 RGD:38549365 |
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
|
RGD |
PMID:9949310 PMID:18186587 |
RGD:5128802 RGD:5128803 |
NCBI chrNW_004955421:24,448,446...24,477,885
Ensembl chrNW_004955421:24,457,496...24,478,744
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
protein, mRNA:increased expression:bronchoalveolar lavage fluid: |
RGD |
PMID:21169467 |
RGD:5509920 |
NCBI chrNW_004955447:1,361,698...1,400,633
Ensembl chrNW_004955447:1,361,566...1,402,491
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
|
ISO |
DNA:polymorphism |
RGD |
PMID:11470996 PMID:17550934 |
RGD:5135038 RGD:5135039 |
NCBI chrNW_004955435:13,253,947...13,256,965
Ensembl chrNW_004955435:13,253,947...13,256,965
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
severity disease_progression no_association susceptibility |
ISO |
DNA:SNP: :p.A114V (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:exon:p.I105V (rs1695) (human) DNA:SNPs:exons:p.I105V (rs1695), A114V (rs1138272) (human) DNA:polymorphism:exon:p.I105V (human) DNA:SNPs: :p.I105V, p.A114V (human) DNA:SNPs:intron,exon:(rs749174), (rs1138272)(human) |
RGD CTD |
PMID:10806136 PMID:11994713 PMID:15693909 PMID:16176403 PMID:16870661 PMID:18057098 PMID:18709160 PMID:18787219 PMID:18988661 PMID:20210814 PMID:20858151 PMID:24117884 PMID:29411558 More...
|
RGD:4140946 RGD:4140947 RGD:4140951 RGD:4142519 RGD:4142526 RGD:5490985 RGD:5490991 RGD:5490999 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
|
RGD |
PMID:20628202 |
RGD:5128851 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
ISO |
|
RGD |
PMID:17517968 |
RGD:5135525 |
NCBI chrNW_004955408:11,289,920...11,311,216
Ensembl chrNW_004955408:11,291,937...11,311,320
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
ISO |
mRNA:decreased expression:macrophage: |
RGD |
PMID:20538962 |
RGD:9590321 |
NCBI chrNW_004955526:2,739,099...2,759,640
Ensembl chrNW_004955526:2,728,377...2,759,707
|
|
G |
Hdc |
histidine decarboxylase |
|
ISO |
associated with Rhinitis;DNA:SNP: :p.E644D (rs2073440) (human) |
RGD |
PMID:20608921 |
RGD:5128884 |
NCBI chrNW_004955409:4,051,574...4,072,641
Ensembl chrNW_004955409:4,051,271...4,072,642
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:18160846 |
RGD:10402541 |
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:20084838 |
RGD:5508450 |
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
|
|
G |
Hmox1 |
heme oxygenase 1 |
severity |
ISO |
mRNA;protein:increased expression:Leukocytes, Mononuclear CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16196283 PMID:18048809 PMID:20596599 |
RGD:4145403 RGD:4145408 |
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
|
|
G |
Hnmt |
histamine N-methyltransferase |
susceptibility no_association |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to |
OMIM ClinVar RGD |
PMID:10752634 PMID:10803682 PMID:15693910 PMID:16205835 PMID:17651147 |
RGD:5128885 RGD:5128887 RGD:5128888 |
NCBI chrNW_004955440:5,084,198...5,137,577
Ensembl chrNW_004955440:5,084,081...5,139,348
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11932298 |
|
NCBI chrNW_004955484:9,206,681...9,212,356
Ensembl chrNW_004955484:9,206,681...9,212,356
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25322896 |
|
NCBI chrNW_004955431:583,165...646,991
Ensembl chrNW_004955431:580,713...647,345
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
mRNA:increased expression:aorta (mouse) CTD Direct Evidence: marker/mechanism protein:increased expression:lung, serum (rat) protein:increased secretion:lung (human) |
RGD CTD |
PMID:17014439 PMID:20205697 PMID:20400685 PMID:20953388 PMID:25003170 |
RGD:4145331 RGD:4145444 RGD:4145509 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Ifng |
interferon gamma |
resistance treatment |
ISO |
protein:increased expression:sputum |
RGD |
PMID:12396623 PMID:19542437 PMID:20817868 PMID:20953328 |
RGD:10755706 RGD:4145525 RGD:4145651 RGD:5128479 |
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
|
ISO |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 PMID:21737883 |
RGD:6480255 RGD:6480431 |
NCBI chrNW_004955436:22,183,318...22,199,013
|
|
G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25256354 |
|
NCBI chrNW_004955451:14,483,669...14,571,108
Ensembl chrNW_004955451:14,484,132...14,536,916
|
|
G |
Il10 |
interleukin 10 |
treatment susceptibility |
ISO |
DNA:polymorphism: :-627C>A (human) CTD Direct Evidence: marker/mechanism protein:decreased expression:plasma |
RGD CTD |
PMID:12938145 PMID:20121766 PMID:20230687 PMID:20237464 PMID:20560982 PMID:20644177 PMID:21998459 PMID:29317916 More...
|
RGD:11046261 RGD:4140421 RGD:4140451 RGD:4140459 RGD:4140471 RGD:4143221 RGD:5131623 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
|
RGD |
PMID:17056578 PMID:17548618 |
RGD:4373570 RGD:4438438 |
NCBI chrNW_004955448:10,611,131...10,617,911
|
|
G |
Il12b |
interleukin 12B |
severity susceptibility |
ISO |
DNA:polymorphism:promoter DNA:polymorphisms:introns: DNA:polymorphisms:promoter, 3'utr: |
RGD |
PMID:12241719 PMID:15322986 PMID:16210052 |
RGD:1600043 RGD:4145428 RGD:4145438 |
NCBI chrNW_004955408:13,302,506...13,316,300
Ensembl chrNW_004955408:13,304,219...13,312,620
|
|
G |
Il13 |
interleukin 13 |
susceptibility severity no_association |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to DNA:polymorphism: :c.-1055C>T (human) protein:increased expression:sputum protein:increased expression:serum DNA:polymorphism:cds:p.R130Q (human) |
OMIM ClinVar RGD |
PMID:10699178 PMID:11588017 PMID:11678850 PMID:11709756 PMID:11758895 PMID:12847555 PMID:12928861 PMID:15356556 PMID:15483090 PMID:15711639 PMID:15879126 PMID:18258919 PMID:18328894 PMID:20198887 More...
|
RGD:4145593 RGD:4145639 RGD:4145777 RGD:4763153 RGD:4763761 |
NCBI chrNW_004955408:4,046,406...4,049,795
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
no_association |
ISO |
DNA:polymorphism: :1050C>T (human) DNA:polymorphism: :1398A>G (human) DNA:polymorphisms:promoter, 3' utr:-281T>G, 1365A>G (human) mRNA:increased expression:bronchus |
RGD |
PMID:10686479 PMID:11714828 PMID:17006604 PMID:17392323 PMID:18480254 PMID:20383033 More...
|
RGD:4892639 RGD:4892646 RGD:4892647 RGD:4892650 RGD:4892654 RGD:4892655 |
NCBI chrNW_004955534:1,157,758...1,205,158
Ensembl chrNW_004955534:1,160,340...1,204,911
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
mRNA:increased expression:bronchus protein:increased expression:serum |
RGD |
PMID:17885690 PMID:20383033 PMID:21462799 |
RGD:4892646 RGD:4892649 RGD:8549521 |
NCBI chrNW_004955490:708,144...758,195
Ensembl chrNW_004955490:709,446...758,272
|
|
G |
Il15 |
interleukin 15 |
no_association |
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:11160248 PMID:15131572 PMID:15843549 PMID:16629787 PMID:19133918 |
RGD:4984421 RGD:4990462 RGD:5000757 RGD:5000758 RGD:5000760 |
NCBI chrNW_004955471:1,496,352...1,583,919
Ensembl chrNW_004955471:1,497,483...1,511,469
|
|
G |
Il16 |
interleukin 16 |
severity no_association |
ISO |
DNA:SNP:promoter:-295T>C (human) associated with Rhinitis;protein:increased expression:respiratory system fluid/secretion protein:increased expression:serum |
RGD |
PMID:10585533 PMID:12872394 PMID:15784111 PMID:16387589 PMID:16734115 |
RGD:5024928 RGD:5024930 RGD:5024934 RGD:5024935 RGD:5024937 |
NCBI chrNW_004955416:11,876,317...11,987,548
|
|
G |
Il17a |
interleukin 17A |
susceptibility |
ISO |
mRNA,protein:increased expression:Leukocytes, Mononuclear, lung, serum protein:increased expression:sputum DNA:SNP:promoter:rs2275913 (human) protein:increased expression:alveolar macrophage |
RGD |
PMID:15730730 PMID:18060619 PMID:18941201 PMID:20351038 PMID:20437253 |
RGD:4839043 RGD:4888527 RGD:4889114 RGD:4889139 RGD:4889152 |
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
|
|
G |
Il17rb |
interleukin 17 receptor B |
|
ISO |
associated with Picornaviridae Infections |
RGD |
PMID:25273095 |
RGD:39128256 |
NCBI chrNW_004955430:3,831,665...3,847,366
Ensembl chrNW_004955430:3,831,667...3,846,788
|
|
G |
Il18 |
interleukin 18 |
susceptibility severity disease_progression |
ISO |
DNA:polymorphism: :c. -105A>C (human) DNA:SNPs:Promoter:c. -607C>A (rs1946518), -137G/C (rs187238) (human) DNA:SNP:promoter: c.-380C>G (rs5744247)(human) protein:increased expression:serum DNA:SNP:promoter:c.and -137G>C (rs187238)(human) |
RGD |
PMID:11174201 PMID:16433859 PMID:17767553 PMID:18200581 PMID:18826499 PMID:19745201 PMID:20497957 More...
|
RGD:4889585 RGD:4889863 RGD:4889898 RGD:4889900 RGD:4889908 RGD:4889910 RGD:4889923 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
ISO |
DNA:SNPs: :multiple (human) DNA:SNP: :rs3771166 (human) |
RGD |
PMID:11972614 PMID:18382474 PMID:18774397 PMID:19910030 PMID:20860503 |
RGD:5024942 RGD:5024945 RGD:5024946 RGD:5024947 RGD:5024948 |
NCBI chrNW_004955470:7,854,995...7,887,810
Ensembl chrNW_004955470:7,854,988...7,887,883
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
protein:increased expression:serum mRNA, protein:increased expression:lung, serum |
RGD |
PMID:15557163 |
RGD:5037236 |
NCBI chrNW_004955406:42,376,102...42,384,902
Ensembl chrNW_004955406:42,376,104...42,384,902
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
DNA:polymorphisms: : |
RGD |
PMID:18763028 |
RGD:4142802 |
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
|
|
G |
Il1b |
interleukin 1 beta |
susceptibility |
ISO |
protein:decreased expression:neutrophil DNA:polymorphism: :-511C>T (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9176529 PMID:18926055 PMID:19684087 PMID:19842845 |
RGD:4142830 RGD:4142836 RGD:4142864 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1rl1 |
interleukin 1 receptor like 1 |
susceptibility severity |
ISO |
DNA:SNP: :rs1041973 (human) DNA:SNPs:intron:rs1420089, rs1861245,rs1946131 (human) protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:SNP: :rs10197862 (human) DNA:SNP: :rs1420101 (human) |
RGD CTD |
PMID:11463601 PMID:17407196 PMID:17623648 PMID:19179489 PMID:19198610 PMID:19852851 PMID:21150878 PMID:21281963 PMID:21804549 PMID:24241537 PMID:27472835 More...
|
RGD:5144235 RGD:5144237 RGD:5144239 RGD:5144240 RGD:5144242 RGD:5144243 RGD:5144244 RGD:5144245 |
NCBI chrNW_004955470:7,779,828...7,849,157
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility severity |
ISO |
DNA:polymorphism:intron (human) CTD Direct Evidence: marker/mechanism DNA:SNP: :rs2234678 (human) protein:increased expression:plasma DNA:SNPs: :rs447713, rs3087271 (human) DNA:SNPs: :multiple (human) DNA, protein:repeat, decreased expression (human) |
RGD CTD |
PMID:9176529 PMID:10843772 PMID:11027520 PMID:15020290 PMID:16409203 PMID:16724092 PMID:17107994 PMID:18763028 PMID:18926055 More...
|
RGD:4142802 RGD:4142864 RGD:4143163 RGD:4143208 RGD:4143209 RGD:4143216 RGD:4143224 RGD:4143225 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
Il2 |
interleukin 2 |
susceptibility |
ISO |
DNA:SNP:promoter:rs2069762(human) |
RGD |
PMID:16333313 PMID:20926789 |
RGD:4889118 RGD:8663473 |
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
DNA:SNP:exon:5250C>T (human) |
RGD |
PMID:18802358 |
RGD:5147396 |
NCBI chrNW_004955428:18,057,096...18,065,492
Ensembl chrNW_004955428:18,057,096...18,065,492
|
|
G |
Il22 |
interleukin 22 |
severity treatment |
ISO |
protein:increased expression:serum mRNA:increased expression:blood, mononuclear cell |
RGD |
PMID:21297073 PMID:21535180 PMID:21998459 |
RGD:11046261 RGD:5147403 RGD:5147409 |
NCBI chrNW_004955458:14,747,339...14,755,602
Ensembl chrNW_004955458:14,747,084...14,752,553
|
|
G |
Il23r |
interleukin 23 receptor |
|
ISO |
|
RGD |
PMID:19935773 |
RGD:5037240 |
NCBI chrNW_004955423:23,841,342...23,885,191
Ensembl chrNW_004955423:23,842,475...23,884,904
|
|
G |
Il25 |
interleukin 25 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:25273095 |
RGD:39128256 |
NCBI chrNW_004955409:36,960,902...36,964,038
Ensembl chrNW_004955409:36,961,398...36,964,038
|
|
G |
Il27 |
interleukin 27 |
treatment susceptibility |
ISO |
protein:increased expression:sputum DNA:SNP: :g.-964A>G (human) |
RGD |
PMID:17318299 PMID:17878337 PMID:19542437 PMID:20817868 PMID:26595888 |
RGD:11076728 RGD:4145651 RGD:5128479 RGD:5128485 RGD:5128491 |
NCBI chrNW_004955493:6,712,005...6,717,417
Ensembl chrNW_004955493:6,712,005...6,717,417
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:16081811 |
RGD:5128496 |
NCBI chrNW_004955415:32,749,682...32,762,532
Ensembl chrNW_004955415:32,749,094...32,761,882
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17351063 PMID:20525707 PMID:21377197 |
RGD:2325990 RGD:5147437 RGD:5147445 |
NCBI chrNW_004955421:22,642,004...22,694,729
Ensembl chrNW_004955421:22,641,511...22,694,913
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
|
ISO |
DNA:SNP: :rs2284033 (human) |
RGD |
PMID:18641329 PMID:20860503 |
RGD:5024942 RGD:5147447 |
NCBI chrNW_004955413:23,623,567...23,640,245
Ensembl chrNW_004955413:23,623,154...23,640,259
|
|
G |
Il33 |
interleukin 33 |
treatment severity |
ISO |
CTD Direct Evidence: marker/mechanism associated with viral pneumonia; associated with fungal infectious disease |
CTD RGD |
PMID:19198610 PMID:21804549 PMID:24241537 PMID:25746970 PMID:27472835 PMID:28947081 PMID:29067999 More...
|
RGD:39938968 RGD:39939002 |
NCBI chrNW_004955434:10,145,449...10,187,595
Ensembl chrNW_004955434:10,171,812...10,188,948
|
|
G |
Il4 |
interleukin 4 |
no_association treatment |
ISO |
protein:increased expression:lung CTD Direct Evidence: marker/mechanism DNA:SNP: :589C>T (human) protein:increased expression:respiratory system fluid/secretion DNA:polymorphism (human) mRNA:increased expression:lung, spleen mRNA, protein:increase expression:leukocyte, serum |
RGD CTD |
PMID:18211752 PMID:18357729 PMID:20524005 PMID:21103062 PMID:21354484 PMID:21364926 PMID:21375458 PMID:24450480 PMID:24946644 More...
|
RGD:10402791 RGD:10402799 RGD:2317290 RGD:4889866 RGD:5128500 RGD:5128502 RGD:5128557 RGD:5128560 |
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Il4r |
interleukin 4 receptor |
disease_progression susceptibility severity |
ISO |
DNA:SNPs:cds:p.E375A, Q551R (human) DNA:polymorphism::-1902G/A (human) DNA:polymorphism:cds:p.I50V (human) DNA:SNPs: :multiple protein:increased secretion:plasma DNA:polymorphism:cds:p.Q551R (human) DNA:polymorphism:cds:p. S478P (human) DNA:polymorphism:cds:p.Q576R (human) DNA:mutation:cds:p.Q576R (mouse) DNA:SNPs:cds:p. I75V, Q576R (human) |
RGD |
PMID:11398072 PMID:11709756 PMID:12133990 PMID:12940513 PMID:15479272 PMID:16917945 PMID:17170387 PMID:17586032 PMID:17823973 PMID:18425216 PMID:19770271 PMID:20605987 PMID:20868478 PMID:20953944 More...
|
RGD:4890003 RGD:4890024 RGD:4890346 RGD:4890347 RGD:4890348 RGD:4890349 RGD:4890351 RGD:4890352 RGD:4890387 RGD:4890402 RGD:4890404 RGD:4890406 RGD:5128514 RGD:5128553 |
NCBI chrNW_004955493:5,546,340...5,580,745
Ensembl chrNW_004955493:5,545,944...5,582,422
|
|
G |
Il5 |
interleukin 5 |
treatment disease_progression |
ISO |
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-703C>T (human) protein: increased levels: sputum protein:increased expression:lungs, respiratory system fluid/secretion |
RGD CTD |
PMID:7540862 PMID:9182686 PMID:9493449 PMID:11159041 PMID:15502111 PMID:15626484 PMID:17074272 PMID:18629290 PMID:19947994 PMID:22085848 PMID:22186238 PMID:23266719 PMID:25008888 More...
|
RGD:11354973 RGD:4145461 RGD:4890938 RGD:4890940 RGD:4890947 RGD:4890948 RGD:4890962 RGD:4890963 RGD:5687140 RGD:5687144 RGD:5687189 |
NCBI chrNW_004955408:3,937,128...3,951,784
Ensembl chrNW_004955408:3,937,894...3,939,358
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
|
ISO |
DNA:SNP: :c.25091G>A (human) DNA:SNPs (human) |
RGD |
PMID:10224351 PMID:10848907 PMID:16217591 PMID:17276963 PMID:20513521 PMID:20592918 More...
|
RGD:5128614 RGD:5128617 RGD:5128623 RGD:5128625 RGD:5128626 RGD:5128627 |
NCBI chrNW_004955421:10,211,594...10,259,760
Ensembl chrNW_004955421:10,221,694...10,259,885
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:lung associated with Hypersensitivity;protein:increased expression:sputum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20658762 PMID:20816188 PMID:20840469 PMID:21115736 PMID:29902480 |
RGD:4143265 RGD:4143266 RGD:4143271 RGD:5128630 |
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17496315 PMID:21115736 PMID:29902480 |
RGD:5128630 RGD:5128662 |
NCBI chrNW_004955545:932,814...979,359
Ensembl chrNW_004955545:950,765...981,762
|
|
G |
Il9 |
interleukin 9 |
|
ISO |
protein:increased expression:sputum, macrophage, cytoplasm protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12153980 PMID:15303135 PMID:15531759 PMID:17446528 PMID:21356110 |
RGD:5128686 RGD:5128690 RGD:5128691 RGD:5128700 RGD:5128707 |
NCBI chrNW_004955408:30,950,816...30,953,571
Ensembl chrNW_004955408:30,950,816...30,953,571
|
|
G |
Il9r |
interleukin 9 receptor |
|
ISO |
|
RGD |
PMID:10629460 |
RGD:5128704 |
NCBI chrNW_004955442:17,115,207...17,128,899
Ensembl chrNW_004955442:17,117,429...17,127,451
|
|
G |
Irak3 |
interleukin 1 receptor associated kinase 3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 5 |
OMIM ClinVar |
PMID:17503328 |
|
NCBI chrNW_004955458:12,839,995...12,880,285
Ensembl chrNW_004955458:12,846,237...12,879,316
|
|
G |
Irf1 |
interferon regulatory factor 1 |
susceptibility no_association |
ISO |
DNA:repeat:intron (human) DNA:polymorphisms:promoter, cds:-300G>T, 4396A>G, 6355G>A (human) protein:increased expression:respiratory tract epithelium |
RGD |
PMID:10225979 PMID:11069564 PMID:16961714 |
RGD:5128723 RGD:5128724 RGD:5128726 |
NCBI chrNW_004955408:3,882,282...3,887,965
Ensembl chrNW_004955408:3,880,155...3,887,973
|
|
G |
Irf3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20673978 |
RGD:5128793 |
NCBI chrNW_004955559:1,223,986...1,228,671
Ensembl chrNW_004955559:1,224,874...1,228,624
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
DNA:SNPs: : |
RGD |
PMID:17556058 |
RGD:5037230 |
NCBI chrNW_004955478:9,788,192...9,830,254
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
associated with Rhinitis,Allergic,Seasonal;protein:increased expression:nasal cavity of mucosa: |
RGD |
PMID:17651148 PMID:20921519 |
RGD:5684385 RGD:8551771 |
NCBI chrNW_004955447:15,810,816...15,851,702
Ensembl chrNW_004955447:15,810,815...15,853,583
|
|
G |
Kif3a |
kinesin family member 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004955408:4,072,823...4,115,975
Ensembl chrNW_004955408:4,069,639...4,115,998
|
|
G |
Lep |
leptin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19705789 |
RGD:5128781 |
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
|
|
G |
Lgals3 |
galectin 3 |
treatment |
ISO |
|
RGD |
PMID:16424226 |
RGD:9685213 |
NCBI chrNW_004955409:8,448,120...8,452,437
Ensembl chrNW_004955409:8,447,774...8,452,438
|
|
G |
LOC102004444 |
beta-defensin 1-like |
susceptibility |
ISO |
DNA:SNP: :-1816 T>C (human) DNA:SNPs:5' utr:g.-52G>A, g.-44C>G, g.-20G>A (human) |
RGD |
PMID:15696078 PMID:16435024 |
RGD:4892254 RGD:4892263 |
NCBI chrNW_004955403:53,643,328...53,644,361
Ensembl chrNW_004955403:53,643,300...53,644,505
|
|
G |
LOC102004641 |
cytochrome b-245 light chain |
susceptibility |
ISO |
DNA:SNPs: :-930A>G, 242C>T, 640A>G (human) DNA:polymorphism: :-930A>G (human) |
RGD |
PMID:18716406 PMID:19459419 |
RGD:4311041 RGD:4772770 |
NCBI chrNW_004955541:2,570,843...2,573,822
Ensembl chrNW_004955541:2,569,727...2,574,118
|
|
G |
LOC102010850 |
cytochrome P450 1A1 |
|
ISO |
mRNA, protein:increased expression, decreased activity:lung |
RGD |
PMID:12415424 |
RGD:4892074 |
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
|
|
G |
LOC102019320 |
mamu class II histocompatibility antigen, DR alpha chain |
susceptibility |
ISO |
DNA:polymorphisms: : |
RGD |
PMID:20159242 |
RGD:13506913 |
NCBI chrNW_004955437:1,109,735...1,114,742
Ensembl chrNW_004955437:1,109,713...1,114,802
|
|
G |
LOC102021597 |
alpha-1-antiproteinase S-like |
|
ISO |
Fisher rats, shown to exhibit hyperactive airway responses at 14 days of age, had higher transcript and protein levels of Serpina1 than same age Brown Norway rats. |
RGD |
PMID:20118217 |
RGD:5131869 |
NCBI chrNW_004955438:17,920,200...17,929,105
|
|
G |
LOC102025724 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:21814517 |
RGD:13506911 |
NCBI chrNW_004955437:1,644,037...1,657,094
Ensembl chrNW_004955437:1,643,238...1,651,071
|
|
G |
LOC102026028 |
cytochrome P450 2E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:leukocyte |
CTD RGD |
PMID:17081494 PMID:20514434 PMID:28807506 |
RGD:4892076 RGD:4892220 |
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
|
|
G |
LOC102026469 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: : DNA:haplotype |
CTD RGD |
PMID:16792590 PMID:17956852 PMID:21217921 PMID:21814517 |
RGD:13506911 RGD:5143938 |
NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042
|
|
G |
Lta |
lymphotoxin alpha |
no_association susceptibility |
ISO |
DNA:polymorphism:intron DNA:polymorphisms:promoter |
RGD |
PMID:12530118 PMID:15969671 PMID:17536219 PMID:18947013 |
RGD:4143254 RGD:4143370 RGD:4143371 RGD:4143373 |
NCBI chrNW_004955437:114,216...116,003
Ensembl chrNW_004955437:114,640...115,529
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
|
ISO |
mRNA:increased expression:lung, cerebral cortex (rat) |
RGD |
PMID:15715933 |
RGD:2316607 |
NCBI chrNW_004955405:32,345,005...32,377,685
Ensembl chrNW_004955405:32,344,925...32,378,384
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:SNP:cds:p.G54D(human) associated with Bronchiolitis;DNA:polymorphism:exon: |
RGD |
PMID:22512728 PMID:22674410 |
RGD:12910828 RGD:8693709 |
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
|
|
G |
Mefv |
MEFV innate immuity regulator, pyrin |
susceptibility |
ISO |
DNA:mutations:exons |
RGD |
PMID:18219832 |
RGD:5129186 |
NCBI chrNW_004955442:14,068,436...14,093,889
Ensembl chrNW_004955442:14,068,348...14,094,016
|
|
G |
Mif |
macrophage migration inhibitory factor |
severity |
ISO |
DNA:SNP:promoter:rs755622(human) DNA:repeats:promoter protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:9637721 PMID:16186482 PMID:16455830 PMID:17373669 PMID:19317738 |
RGD:1641985 RGD:4891035 RGD:4891043 RGD:4891052 RGD:4891059 |
NCBI chrNW_004955455:8,367,566...8,368,460
Ensembl chrNW_004955455:8,367,566...8,368,460
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16926187 |
|
NCBI chrNW_004955412:5,965,388...5,976,353
Ensembl chrNW_004955412:5,965,394...5,976,382
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP: : rs2664538(human) protein:increased expression:serum protein:increased expression:lung mRNA, protein:increased expression:lung |
CTD RGD |
PMID:11742282 PMID:15131573 PMID:16191269 PMID:19361849 PMID:19940022 PMID:20181264 PMID:21439806 More...
|
RGD:2325953 RGD:5129204 RGD:5129522 RGD:5129687 RGD:5130859 |
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Mpo |
myeloperoxidase |
susceptibility |
ISO |
protein:increased expression:serum DNA:polymorphism: :−463G > A (human) |
RGD |
PMID:10731862 PMID:19544176 |
RGD:5130989 RGD:5130994 |
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
susceptibility |
ISO |
DNA:SNPs:multiple:, rs573790, rs2583476, rs569108 Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G DNA:SNPs: : rs556917, rs502581, rs502419 (human) DNA:SNP: : -109C>T (human) |
RGD |
PMID:8817330 PMID:19218813 PMID:19862939 PMID:21320344 |
RGD:1599903 RGD:5131092 RGD:5131149 RGD:5131151 |
NCBI chrNW_004955511:4,377,894...4,400,797
Ensembl chrNW_004955511:4,380,502...4,400,852
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
DNA:transition:cds:g.677C>T (human) |
RGD |
PMID:20456312 |
RGD:4891145 |
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:11802251 |
RGD:5131281 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
associated with hypersensitivity |
RGD |
PMID:11062147 PMID:14594655 |
RGD:5131178 RGD:7349354 |
NCBI chrNW_004955476:11,108,826...11,135,697
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
treatment |
ISO |
protein:increased expression:lung mRNA, protein:increased expression:lung mRNA,protein:increased expression:lung |
RGD |
PMID:14594655 PMID:17590487 PMID:17698377 PMID:21549818 PMID:21780541 |
RGD:2324962 RGD:5131204 RGD:7349354 RGD:7349407 RGD:7364729 |
NCBI chrNW_004955476:11,061,405...11,084,294
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
protein:altered expression:sputum |
RGD |
PMID:11587997 PMID:11802783 |
RGD:5131252 RGD:7364763 |
NCBI chrNW_004955476:11,021,665...11,049,239
|
|
G |
Muc7 |
mucin 7, secreted |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma, protection against |
OMIM ClinVar |
PMID:11378823 PMID:16759176 |
|
NCBI chrNW_004955447:2,511,841...2,520,312
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19198610 |
|
NCBI chrNW_004955439:1,523,516...1,560,185
Ensembl chrNW_004955439:1,521,292...1,560,220
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
ameliorates |
ISO |
|
RGD |
PMID:26882889 |
RGD:11531666 |
NCBI chrNW_004955427:25,553,589...25,557,654
Ensembl chrNW_004955427:25,553,589...25,559,138
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
|
RGD |
PMID:17472811 |
RGD:4891492 |
NCBI chrNW_004955427:22,760,432...23,008,432
Ensembl chrNW_004955427:22,762,221...22,970,508
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
severity |
ISO |
mRNA:increased expression:bronchoalveolar lavage cell, peripheral blood mononuclear cell (human) |
RGD |
PMID:21514635 |
RGD:6893376 |
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Ngf |
nerve growth factor |
severity |
ISO |
protein:increased expression:blood, eosinophil protein:increased expression:lung, serum |
RGD |
PMID:11737043 PMID:12752594 PMID:17164945 PMID:17497413 |
RGD:4891068 RGD:4891108 RGD:4891122 RGD:4891123 |
NCBI chrNW_004955435:18,581,889...18,633,330
Ensembl chrNW_004955435:18,581,808...18,601,059
|
|
G |
Ngfr |
nerve growth factor receptor |
|
ISO |
|
RGD |
PMID:12540484 PMID:16603479 |
RGD:5144070 RGD:5144072 |
NCBI chrNW_004955451:12,030,303...12,047,305
Ensembl chrNW_004955451:12,030,252...12,047,305
|
|
G |
Nod1 |
nucleotide binding oligomerization domain containing 1 |
susceptibility |
ISO |
DNA:SNP: :rs2075817 (human) DNA:insertion:cds: |
RGD |
PMID:15718249 PMID:16918516 |
RGD:5131518 RGD:5131519 |
NCBI chrNW_004955410:31,681,191...31,725,173
Ensembl chrNW_004955410:31,681,077...31,725,173
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
susceptibility |
ISO |
DNA:polymorphisms:intron, exon/3'UTR (rs1077861, rs3135500) (human) |
RGD |
PMID:16008671 PMID:21051079 |
RGD:5131477 RGD:5508757 |
NCBI chrNW_004955433:8,746,213...8,780,119
Ensembl chrNW_004955433:8,746,004...8,782,710
|
|
G |
Nos1 |
nitric oxide synthase 1 |
susceptibility |
ISO |
DNA:repeats:intron DNA:repeats:exon DNA:repeats: : |
RGD |
PMID:10673365 PMID:10833424 PMID:14767694 PMID:20609134 |
RGD:5132615 RGD:5132860 RGD:5132863 RGD:5132869 |
NCBI chrNW_004955455:13,797,557...13,978,402
Ensembl chrNW_004955455:13,797,545...13,972,566
|
|
G |
Nos2 |
nitric oxide synthase 2 |
no_association severity disease_progression |
ISO |
DNA:repeat:promoter protein:increased expression, increased activity:lung (rat) DNA:repeats:promoter, introns (human) CTD Direct Evidence: marker/mechanism DNA:SNP:exon:p.S608L (human) associated with Rhinitis, Allergic, Seasonal; protein:increased expression:nasal mucosa mRNA:increased expression:monocyte protein:increased expression:lung, bronchoalveolar lavage fluid |
RGD CTD |
PMID:16540403 PMID:16703578 PMID:17161822 PMID:17177683 PMID:17189532 PMID:18254476 PMID:18714530 PMID:19800904 PMID:20841959 PMID:20842520 PMID:21847581 More...
|
RGD:4891419 RGD:4891480 RGD:4891508 RGD:4891910 RGD:4891924 RGD:4891925 RGD:4891927 RGD:4891953 RGD:4891957 RGD:5509073 |
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
Nos3 |
nitric oxide synthase 3 |
susceptibility |
ISO |
DNA:polymorphisms:promoter:c. -786C>T, -691C>T (human) DNA:repeats:intron DNA:snps, repeat, haplotype:promoter, introns, exons:multiple (human) |
RGD |
PMID:16081038 PMID:16837812 PMID:18486767 |
RGD:4892053 RGD:4892058 RGD:4892062 |
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
Npsr1 |
neuropeptide S receptor 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 2 |
OMIM ClinVar |
PMID:15073379 |
|
NCBI chrNW_004955560:1,069,651...1,243,111
Ensembl chrNW_004955560:1,069,651...1,243,111
|
|
G |
Npy |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chrNW_004955410:26,348,388...26,355,232
Ensembl chrNW_004955410:26,348,504...26,355,297
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
susceptibility |
ISO |
DNA:SNP:exon:c. 609C>T (human) DNA:SNP:exon:c.609C>T (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19027876 PMID:19591959 PMID:20049212 |
RGD:5135005 RGD:5135006 |
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
severity susceptibility treatment |
ISO |
protein:increased expression, decreased activity:leukocyte, mononuclear DNA:polymorphism:intron |
RGD |
PMID:15295049 PMID:18396779 PMID:18799869 PMID:20727335 PMID:21113676 |
RGD:4892328 RGD:4892568 RGD:4892594 RGD:4892609 RGD:7174728 |
NCBI chrNW_004955415:10,494,704...10,585,778
Ensembl chrNW_004955415:10,494,640...10,586,221
|
|
G |
Ntf3 |
neurotrophin 3 |
|
ISO |
protein:increased expression:lung, serum |
RGD |
PMID:11737043 PMID:17497413 |
RGD:4891068 RGD:4891123 |
NCBI chrNW_004955413:3,207,669...3,273,371
Ensembl chrNW_004955413:3,207,123...3,273,491
|
|
G |
Ntf4 |
neurotrophin 4 |
|
ISO |
protein:increased expression:lung, serum |
RGD |
PMID:17497413 |
RGD:4891068 |
NCBI chrNW_004955559:1,647,685...1,650,553
Ensembl chrNW_004955559:1,647,685...1,650,553
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:16708804 PMID:20934630 |
RGD:5684766 RGD:5684772 |
NCBI chrNW_004955545:2,929,704...2,947,579
Ensembl chrNW_004955545:2,929,704...2,947,579
|
|
G |
Ormdl3 |
ORMDL sphingolipid biosynthesis regulator 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21150878 PMID:25256354 |
|
NCBI chrNW_004955451:14,621,565...14,627,556
Ensembl chrNW_004955451:14,621,399...14,642,763
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
|
ISO |
|
RGD |
PMID:19822647 PMID:22010907 |
RGD:6480532 RGD:6480533 |
NCBI chrNW_004955448:2,442,368...2,488,567
Ensembl chrNW_004955448:2,442,368...2,488,567
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased activation:lung, blood, mononuclear cell |
CTD RGD |
PMID:12594058 PMID:18261157 PMID:26205779 |
RGD:11073727 RGD:5683910 |
NCBI chrNW_004955489:520,875...557,609
Ensembl chrNW_004955489:520,875...557,615
|
|
G |
Pdcd1 |
programmed cell death 1 |
treatment |
ISO |
associated with Chlamydia pneumonia |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chrNW_004955542:49,290...57,747
Ensembl chrNW_004955542:49,259...58,823
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004955423:24,464,503...24,906,409
Ensembl chrNW_004955423:24,463,953...24,906,394
|
|
G |
Pde4d |
phosphodiesterase 4D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19426955 PMID:21611147 |
|
NCBI chrNW_004955446:7,914,326...9,252,527
Ensembl chrNW_004955446:8,211,877...9,252,653
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
protein: increased expression |
RGD |
PMID:21216974 |
RGD:6483071 |
NCBI chrNW_004955413:25,150,702...25,166,987
Ensembl chrNW_004955413:25,148,062...25,166,987
|
|
G |
Pgf |
placental growth factor |
|
ISO |
|
RGD |
PMID:22268141 |
RGD:6483605 |
NCBI chrNW_004955523:616,196...627,055
Ensembl chrNW_004955523:616,154...627,713
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:18754810 |
RGD:6482695 |
NCBI chrNW_004955410:11,402,476...11,433,335
Ensembl chrNW_004955410:11,402,520...11,437,422
|
|
G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
ISO |
|
RGD |
PMID:18188456 |
RGD:8693422 |
NCBI chrNW_004955495:1,250,557...1,261,617
Ensembl chrNW_004955495:1,250,453...1,266,235
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
ISO |
|
RGD |
PMID:15557087 |
RGD:1642462 |
NCBI chrNW_004955406:25,257,361...25,392,079
Ensembl chrNW_004955406:25,257,355...25,394,206
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma and atopy, susceptibility to |
OMIM ClinVar |
PMID:10733466 PMID:15115767 |
|
NCBI chrNW_004955437:11,534,251...11,577,942
Ensembl chrNW_004955437:11,534,173...11,555,996
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18519237 PMID:21912604 |
RGD:4892037 |
NCBI chrNW_004955437:17,995,726...18,000,542
Ensembl chrNW_004955437:17,994,537...18,000,209
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22205926 |
|
NCBI chrNW_004955408:5,435,117...5,460,361
Ensembl chrNW_004955408:5,433,268...5,460,361
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:21426642 PMID:22250087 |
RGD:6482815 RGD:6482818 |
NCBI chrNW_004955437:20,700,912...20,705,076
Ensembl chrNW_004955437:20,700,718...20,706,929
|
|
G |
Prmt1 |
protein arginine methyltransferase 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004955559:1,205,340...1,215,672
Ensembl chrNW_004955559:1,203,283...1,215,021
|
|
G |
Prmt2 |
protein arginine methyltransferase 2 |
|
ISO |
mRNA:increased expression:lung, spleen |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004955407:42,991,305...43,019,332
Ensembl chrNW_004955407:42,992,469...43,018,760
|
|
G |
Prmt3 |
protein arginine methyltransferase 3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004955476:1,222,579...1,331,582
Ensembl chrNW_004955476:1,223,076...1,331,582
|
|
G |
Prmt5 |
protein arginine methyltransferase 5 |
|
ISO |
mRNA:increased expression:lung, spleen |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004955409:37,369,507...37,378,034
Ensembl chrNW_004955409:37,369,234...37,378,093
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:26381519 |
RGD:11099992 |
NCBI chrNW_004955459:3,097,229...3,105,566
Ensembl chrNW_004955459:3,094,120...3,104,135
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17982072 |
|
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
|
|
G |
Ptgdr |
prostaglandin D2 receptor |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chrNW_004955409:10,801,370...10,810,161
Ensembl chrNW_004955409:10,801,328...10,810,066
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
Aspirin exacerbated asthma CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:18757520 PMID:19392992 PMID:19796209 PMID:27103662 |
RGD:5135018 RGD:5135019 RGD:5135020 |
NCBI chrNW_004955511:5,536,602...5,539,944
Ensembl chrNW_004955511:5,536,642...5,537,926
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
treatment |
ISO |
|
RGD |
PMID:23221044 |
RGD:10043366 |
NCBI chrNW_004955423:21,096,926...21,164,435
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
susceptibility severity |
ISO |
mRNA, protein:increased expression:lung: DNA:SNP: :rs689465 (human) mRNA:increased expression:lung DNA:SNP: :8473T>C (human) |
RGD |
PMID:15316498 PMID:17573729 PMID:18097056 PMID:18489027 PMID:19342146 PMID:19862936 PMID:19878559 More...
|
RGD:5135514 RGD:5135515 RGD:5135522 RGD:5135526 RGD:5135534 RGD:5143923 RGD:5143931 |
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241537 |
|
NCBI chrNW_004955408:3,953,801...4,035,494
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
|
RGD |
PMID:18391481 |
RGD:2298885 |
NCBI chrNW_004955532:1,300,821...1,347,453
Ensembl chrNW_004955532:1,300,462...1,347,451
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
DNA:SNPs: :multiple |
RGD |
PMID:21803869 |
RGD:6482835 |
NCBI chrNW_004955407:34,108,653...34,342,657
Ensembl chrNW_004955407:34,104,035...34,342,928
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
susceptibility |
ISO |
associated with allergic rhinitis; DNA:SNP:exon:38G>A (human) ClinVar Annotator: match by term: Asthma, susceptibility to |
RGD ClinVar |
PMID:9550363 PMID:21255142 |
RGD:5144226 |
NCBI chrNW_004955599:688,414...690,644
|
|
G |
Scgb3a2 |
secretoglobin family 3A member 2 |
susceptibility no_association severity |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to DNA:SNP:promoter:-112G>A (human) |
OMIM ClinVar RGD |
PMID:11813133 PMID:18089940 PMID:18201431 |
RGD:5144230 RGD:5144231 |
NCBI chrNW_004955415:6,332,121...6,335,474
Ensembl chrNW_004955415:6,331,535...6,335,462
|
|
G |
Sell |
selectin L |
|
ISO |
|
RGD |
PMID:21437035 PMID:21515793 |
RGD:5685685 RGD:5685696 |
NCBI chrNW_004955462:7,591,997...7,611,408
Ensembl chrNW_004955462:7,591,366...7,612,846
|
|
G |
Serpine1 |
serpin family E member 1 |
no_association susceptibility severity |
ISO |
DNA:polymorphism:promoter:rs1799768 (human) protein:increased expression:plasma protein:increased activity, increased expression:plasma, lung |
RGD |
PMID:18594148 PMID:19063817 PMID:19604112 PMID:19703828 |
RGD:4144831 RGD:4144832 RGD:4144833 RGD:4144836 |
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
|
|
G |
Sftpb |
surfactant protein B |
|
ISO |
protein:increased expression:lung mRNA, protein:decreased expression:lung protein:decreased expression:lung, Clara cell |
RGD |
PMID:11472974 PMID:15816355 PMID:16629790 PMID:18926058 |
RGD:4143289 RGD:4143398 RGD:4143462 RGD:4143465 |
NCBI chrNW_004955424:1,849,313...1,858,087
Ensembl chrNW_004955424:1,849,314...1,858,087
|
|
G |
Sftpc |
surfactant protein C |
susceptibility |
ISO |
DNA:polymorphism: :p.A53T (human) protein:increased expression:lung mRNA, protein:decreased expression:lung |
RGD |
PMID:11472974 PMID:16629790 PMID:19910179 |
RGD:4143462 RGD:4143465 RGD:4144063 |
NCBI chrNW_004955403:45,649,149...45,651,421
Ensembl chrNW_004955403:45,649,122...45,651,837
|
|
G |
Sftpd |
surfactant protein D |
|
ISO |
associated with Bronchitis;protein:increased expression:lung mRNA, protein:increased expression:lung |
RGD |
PMID:11472974 PMID:16629790 PMID:16839409 PMID:18266831 PMID:18802356 |
RGD:4143462 RGD:4143465 RGD:4143508 RGD:4143516 RGD:4143517 |
NCBI chrNW_004955510:213,468...226,096
Ensembl chrNW_004955510:213,438...225,896
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
|
RGD |
PMID:12847242 |
RGD:5684966 |
NCBI chrNW_004955453:14,980,562...14,995,118
Ensembl chrNW_004955453:14,980,562...14,995,608
|
|
G |
Slc18a3 |
solute carrier family 18 member A3 |
|
ISO |
|
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004955556:696,779...698,869
Ensembl chrNW_004955556:696,974...698,566
|
|
G |
Slc5a7 |
solute carrier family 5 member 7 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004955470:11,673,491...11,694,404
Ensembl chrNW_004955470:11,673,465...11,697,163
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
susceptibility |
ISO |
DNA:repeat:intron (human) |
RGD |
PMID:19806585 |
RGD:4889460 |
NCBI chrNW_004955481:3,088,440...3,122,421
Ensembl chrNW_004955481:3,088,416...3,125,711
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22867017 |
|
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
|
RGD |
PMID:15743779 |
RGD:1581231 |
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28807506 |
|
NCBI chrNW_004955403:8,061,471...8,144,252
Ensembl chrNW_004955403:8,061,471...8,144,276
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
treatment |
ISO |
|
RGD |
PMID:16083555 PMID:19087723 |
RGD:7244151 RGD:7244153 |
NCBI chrNW_004955458:4,833,417...4,847,956
Ensembl chrNW_004955458:4,833,515...4,843,273
|
|
G |
Tac1 |
tachykinin precursor 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11031342 |
RGD:5147836 |
NCBI chrNW_004955432:13,991,647...13,999,665
Ensembl chrNW_004955432:13,991,414...13,999,728
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
protein:increased expression:lung mRNA:increased expression:lung mRNA,protein:increased expression:lung |
RGD |
PMID:8240667 PMID:16409782 PMID:17392578 |
RGD:2304339 RGD:5147475 RGD:5147645 |
NCBI chrNW_004955424:10,614,340...10,761,872
Ensembl chrNW_004955424:10,614,340...10,761,872
|
|
G |
Tacr2 |
tachykinin receptor 2 |
|
ISO |
DNA:SNP:cds:p.G231E (human) |
RGD |
PMID:19880429 PMID:20175803 |
RGD:5147640 RGD:5147641 |
NCBI chrNW_004955437:21,719,246...21,731,963
Ensembl chrNW_004955437:21,719,246...21,731,963
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:12640628 |
RGD:5147845 |
NCBI chrNW_004955437:1,504,549...1,511,110
Ensembl chrNW_004955437:1,504,947...1,511,097
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15806396 |
|
NCBI chrNW_004955451:13,315,237...13,317,888
Ensembl chrNW_004955451:13,315,859...13,325,937
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility severity |
ISO |
DNA:polymorphism:cds:924T>C(human) |
RGD |
PMID:12000493 PMID:15805995 |
RGD:11059534 RGD:11059535 |
NCBI chrNW_004955495:5,539,382...5,557,441
Ensembl chrNW_004955495:5,539,889...5,557,441
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
no_association onset |
ISO |
DNA:SNP:cds:915G>C (human) mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism protein:increased expression:serum DNA:SNP: :-509C>T (human) DNA:polymorphisms: :multiple (human) DNA:SNPs:promoter, exon:multiple (human) DNA:polymorphism: :-509C>T (human) |
RGD CTD |
PMID:16365456 PMID:17673695 PMID:18366906 PMID:18711258 PMID:19046298 PMID:19096005 PMID:19136038 PMID:19138248 PMID:19222424 PMID:19317336 PMID:19533439 PMID:19620629 PMID:20485865 More...
|
RGD:4143443 RGD:4145113 RGD:4145132 RGD:4145139 RGD:4145142 RGD:4145143 RGD:4145144 RGD:4145280 RGD:4145295 RGD:4145297 RGD:4145299 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:20709825 |
RGD:5684984 |
NCBI chrNW_004955415:30,222,830...30,226,406
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16926187 |
|
NCBI chrNW_004955405:41,613,976...41,655,813
Ensembl chrNW_004955405:41,613,966...41,655,813
|
|
G |
Tlr1 |
toll like receptor 1 |
susceptibility |
ISO |
DNA:SNP (human) |
RGD |
PMID:18547625 |
RGD:4889528 |
NCBI chrNW_004955443:8,442,419...8,450,318
Ensembl chrNW_004955443:8,447,956...8,450,382
|
|
G |
Tlr10 |
toll like receptor 10 |
susceptibility |
ISO |
DNA:SNP (human) |
RGD |
PMID:18547625 |
RGD:4889528 |
NCBI chrNW_004955443:8,442,439...8,468,966
Ensembl chrNW_004955443:8,462,852...8,469,812
|
|
G |
Tlr2 |
toll like receptor 2 |
susceptibility severity |
ISO |
DNA:SNP: :rs7656411 (human) DNA:SNP: :rs3804100 (human) DNA:polymorphism:cds:p.R753Q(human) DNA:SNP: :rs4696480 (human) DNA:SNP: :596T>C (human) |
RGD |
PMID:18202345 PMID:18787777 PMID:19096003 PMID:19148143 PMID:20685742 PMID:20815312 PMID:22402138 More...
|
RGD:2312679 RGD:4144171 RGD:4144228 RGD:4145334 RGD:4145343 RGD:4145352 RGD:7800732 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tlr3 |
toll like receptor 3 |
no_association |
ISO |
DNA:snp:cds:p.L412F (human) Asthma, Virus-Induced; mRNA:increased expression:sputum (human) |
RGD |
PMID:14987294 PMID:17434873 PMID:17610940 PMID:21129050 PMID:21364926 |
RGD:5128500 RGD:5129226 RGD:5129475 RGD:5129478 RGD:5129493 |
NCBI chrNW_004955403:22,977,882...23,001,392
Ensembl chrNW_004955403:22,979,120...23,001,467
|
|
G |
Tlr4 |
toll like receptor 4 |
susceptibility severity no_association |
ISO |
protein:decreased expression:leukocytes, mononuclear DNA:Polymorphism:cds:p.D299G (human) DNA:polymorphisms:cds:c.896A>G, 1196C>T (human) DNA:SNPs: :rs10983755, rs1927914 (human) DNA:SNPs:: |
RGD |
PMID:15356557 PMID:16266379 PMID:19067129 PMID:19159017 PMID:19330007 PMID:20628601 PMID:20685742 More...
|
RGD:4144141 RGD:4144171 RGD:4144176 RGD:4144188 RGD:4144190 RGD:4144198 RGD:4144817 |
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tlr6 |
toll like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) DNA:SNP (human) |
RGD |
PMID:15266299 PMID:18547625 |
RGD:4889528 RGD:4889538 |
NCBI chrNW_004955443:8,401,461...8,427,175
Ensembl chrNW_004955443:8,422,534...8,424,942
|
|
G |
Tlr9 |
toll like receptor 9 |
no_association susceptibility severity |
ISO |
DNA:SNP:promoter:g.-1237T>C rs5743836 (human) DNA:SNP:promoter:g.-1237T>C (rs5743836) (human) protein:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:18312481 PMID:20016192 PMID:20072849 PMID:21324137 |
RGD:4144208 RGD:4889523 RGD:5129104 RGD:5130712 |
NCBI chrNW_004955532:3,828,645...3,832,699
|
|
G |
Tnc |
tenascin C |
|
ISO |
protein:increased expression:bronchus basement membrane DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism DNA:SNP:exon:p.L1677I (human) |
RGD CTD |
PMID:9310019 PMID:16115819 PMID:17125141 PMID:18305139 |
RGD:4889565 RGD:4889569 RGD:4889572 RGD:4889589 |
NCBI chrNW_004955419:12,569,620...12,662,897
Ensembl chrNW_004955419:12,569,547...12,662,958
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility no_association |
ISO |
ClinVar Annotator: match by term: ASTHMA, BRONCHIAL DNA:polymorphism:promoter: |
OMIM ClinVar RGD |
PMID:8056188 PMID:9818939 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12485196 PMID:12530118 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16720636 PMID:16865291 PMID:16909270 PMID:18050183 PMID:18713756 PMID:19365401 PMID:22760475 PMID:22992668 More...
|
RGD:4143254 |
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:20484920 |
RGD:5131201 |
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
|
|
G |
Tnip1 |
TNFAIP3 interacting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24453940 |
|
NCBI chrNW_004955408:2,575,324...2,621,845
Ensembl chrNW_004955408:2,594,756...2,621,304
|
|
G |
Trpa1 |
transient receptor potential cation channel subfamily A member 1 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism ovalbumin sensitization |
CTD RGD |
PMID:19458046 PMID:31969645 |
RGD:127285811 |
NCBI chrNW_004955444:7,876,284...7,922,010
Ensembl chrNW_004955444:7,876,429...7,921,372
|
|
G |
Tslp |
thymic stromal lymphopoietin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21804549 |
|
NCBI chrNW_004955418:4,041,529...4,045,534
|
|
G |
Ucn |
urocortin |
|
ISO |
associated with Hypersensitivity;mRNA, protein:increased expression:lung |
RGD |
PMID:16427607 |
RGD:1642781 |
NCBI chrNW_004955469:9,277,637...9,278,641
Ensembl chrNW_004955469:9,277,637...9,278,641
|
|
G |
Uts2 |
urotensin 2 |
|
ISO |
|
RGD |
PMID:17045018 |
RGD:2306832 |
NCBI chrNW_004955486:5,052,045...5,056,610
Ensembl chrNW_004955486:5,052,045...5,056,610
|
|
G |
Vdr |
vitamin D receptor |
no_association |
ISO |
DNA:SNPs: :multiple (human) DNA:SNPs (human) DNA:SNP (human) DNA:SNP: :rs7975232 (human) |
RGD |
PMID:15282200 PMID:19622139 PMID:20124605 PMID:21103062 |
RGD:4889854 RGD:4889866 RGD:4889867 RGD:4889868 |
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:sputum |
CTD RGD |
PMID:11907124 PMID:15201500 PMID:19178538 PMID:19263519 |
RGD:6892723 |
NCBI chrNW_004955437:9,527,445...9,541,908
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:16782752 PMID:21419198 |
RGD:5685381 RGD:5685620 |
NCBI chrNW_004955439:9,021,923...9,031,783
Ensembl chrNW_004955439:9,021,904...9,031,792
|
|
G |
Wdr36 |
WD repeat domain 36 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19198610 |
|
NCBI chrNW_004955418:3,988,073...4,023,425
Ensembl chrNW_004955418:3,988,073...4,023,974
|
|
|
G |
LOC102019320 |
mamu class II histocompatibility antigen, DR alpha chain |
susceptibility |
ISO |
DNA:SNPs,haplotype:introns: |
RGD |
PMID:22391069 |
RGD:13506908 |
NCBI chrNW_004955437:1,109,735...1,114,742
Ensembl chrNW_004955437:1,109,713...1,114,802
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma and nasal polyps |
ClinVar |
PMID:15806396 |
|
NCBI chrNW_004955451:13,315,237...13,317,888
Ensembl chrNW_004955451:13,315,859...13,325,937
|
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:17959182 PMID:21558275 PMID:30643255 |
|
NCBI chrNW_004955467:10,032,792...10,039,789
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004955409:10,760,801...10,775,197
Ensembl chrNW_004955409:10,757,888...10,774,688
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
OMIM ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955451:13,315,237...13,317,888
Ensembl chrNW_004955451:13,315,859...13,325,937
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27869817 |
|
NCBI chrNW_004955410:20,428,531...20,459,482
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:19116453 |
RGD:11040546 |
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
|
|
G |
Artn |
artemin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27869817 |
|
NCBI chrNW_004955537:3,460,176...3,464,335
Ensembl chrNW_004955537:3,460,176...3,464,335
|
|
G |
Bdnf |
brain derived neurotrophic factor |
no_association susceptibility |
ISO |
DNA:polymorphism:cds:p.V66M(human) DNA:polymorphism::C270T(human) protein:increased expression:serum: mRNA:decreased expression:mast cell |
RGD |
PMID:17073871 PMID:17845420 PMID:19038326 PMID:19522715 |
RGD:8657028 RGD:8657065 RGD:8657067 RGD:8657069 |
NCBI chrNW_004955476:6,773,244...6,822,201
Ensembl chrNW_004955476:6,772,088...6,822,588
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:3923750 |
RGD:7401273 |
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
|
|
G |
Card11 |
caspase recruitment domain family member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23042114 PMID:28628108 |
|
NCBI chrNW_004955460:12,368,987...12,487,675
Ensembl chrNW_004955460:12,368,918...12,490,041
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23042114 |
|
NCBI chrNW_004955427:12,945,230...12,975,020
Ensembl chrNW_004955427:12,945,230...12,975,114
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955433:15,052,616...15,054,732
Ensembl chrNW_004955433:15,053,061...15,054,572
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
severity treatment |
ISO |
protein:increased expression:plasma |
RGD |
PMID:11133838 PMID:19162238 |
RGD:7483580 RGD:7483583 |
NCBI chrNW_004955453:6,846,625...6,850,007
Ensembl chrNW_004955453:6,846,549...6,850,031
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 PMID:22125604 |
|
NCBI chrNW_004955433:15,002,001...15,007,324
Ensembl chrNW_004955433:15,001,930...15,008,032
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955456:14,582,812...14,588,574
Ensembl chrNW_004955456:14,583,610...14,585,169
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:14616792 |
RGD:11087554 |
NCBI chrNW_004955456:14,554,583...14,558,967
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
|
ISO |
|
RGD |
PMID:12642842 |
RGD:1626250 |
NCBI chrNW_004955472:1,470,407...1,474,800
Ensembl chrNW_004955472:1,471,551...1,474,777
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
severity |
ISO |
associated with Asthma; protein: increased secretion:serum (human) |
RGD |
PMID:20161852 |
RGD:4892193 |
NCBI chrNW_004955446:18,902,465...18,925,178
Ensembl chrNW_004955446:18,902,636...18,925,561
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
protein:increased expression:skin,monocyte: |
RGD |
PMID:15370700 |
RGD:8661734 |
NCBI chrNW_004955420:25,641,184...25,664,413
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:skin |
CTD RGD |
PMID:16449815 PMID:18249437 |
RGD:6893391 |
NCBI chrNW_004955420:25,702,917...25,723,269
Ensembl chrNW_004955420:25,701,407...25,723,353
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:18693155 |
RGD:5132274 |
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
|
|
G |
Cdsn |
corneodesmosin |
|
ISO |
protein:decreased expression:skin of body (human) |
RGD |
PMID:21211653 |
RGD:42721970 |
NCBI chrNW_004955583:959,544...968,632
Ensembl chrNW_004955583:958,668...964,149
|
|
G |
Cldn1 |
claudin 1 |
|
ISO |
DNA:SNPs:intron,promoter :rs17501010,rs9290927,rs893051,rs9290929,rs16865373(human) |
RGD |
PMID:21163515 |
RGD:11344875 |
NCBI chrNW_004955420:17,798,974...17,815,049
Ensembl chrNW_004955420:17,798,974...17,815,205
|
|
G |
Cldn23 |
claudin 23 |
|
ISO |
mRNA:decreased expression:epidermis: |
RGD |
PMID:21163515 |
RGD:11344875 |
NCBI chrNW_004955463:4,740,476...4,742,283
Ensembl chrNW_004955463:4,740,544...4,741,431
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
susceptibility |
ISO |
DNA:SNP,haplotype:exon,3'UTR:rs3087243,rs231775 (human) mRNA:increased expression:blood: |
RGD |
PMID:16445777 PMID:22357516 |
RGD:7411698 RGD:7411700 |
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15131578 |
RGD:9491761 |
NCBI chrNW_004955433:15,023,272...15,034,650
Ensembl chrNW_004955433:15,023,050...15,034,711
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
protein:decreased expression:blood, leukocyte |
RGD |
PMID:15131578 PMID:24821910 |
RGD:9491393 RGD:9491761 |
NCBI chrNW_004955427:24,691,206...24,705,599
Ensembl chrNW_004955427:24,701,073...24,707,230
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955475:11,148,928...11,152,313
Ensembl chrNW_004955475:11,148,879...11,152,596
|
|
G |
Dock8 |
dedicator of cytokinesis 8 |
|
ISO |
DNA:mutations:cds: |
RGD |
PMID:22476911 |
RGD:40903056 |
NCBI chrNW_004955434:4,849,147...5,050,545
Ensembl chrNW_004955434:4,867,016...5,049,118
|
|
G |
Emsy |
EMSY transcriptional repressor, BRCA2 interacting |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23042114 |
|
NCBI chrNW_004955414:15,395,851...15,482,490
Ensembl chrNW_004955414:15,401,664...15,477,828
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:21488867 |
RGD:5147756 |
NCBI chrNW_004955422:1,356,675...1,367,788
Ensembl chrNW_004955422:1,356,769...1,367,517
|
|
G |
Glb1 |
galactosidase beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23042114 |
|
NCBI chrNW_004955421:230,957...311,504
Ensembl chrNW_004955421:231,076...312,500
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:19842992 PMID:20674822 |
RGD:5490540 RGD:5490981 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
|
RGD |
PMID:16159638 |
RGD:5128852 |
NCBI chrNW_004955408:11,047,679...11,070,492
|
|
G |
Hnmt |
histamine N-methyltransferase |
|
ISO |
|
RGD |
PMID:19025430 |
RGD:5128889 |
NCBI chrNW_004955440:5,084,198...5,137,577
Ensembl chrNW_004955440:5,084,081...5,139,348
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18249437 PMID:22101570 |
RGD:8157618 |
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18249437 PMID:23843958 |
RGD:7364805 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il13 |
interleukin 13 |
severity treatment |
ISO |
DNA:SNP:exon:4257G>A (human) DNA, protein:SNP, increased expression:promoter, serum:-1112C>T (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :rs3091307, rs20541 (human) |
RGD CTD |
PMID:10887320 PMID:16672002 PMID:17313488 PMID:18249437 PMID:19006098 PMID:21913997 PMID:22355542 PMID:23317483 More...
|
RGD:5684364 RGD:8549509 RGD:8549529 RGD:8549531 RGD:8549539 RGD:8549583 |
NCBI chrNW_004955408:4,046,406...4,049,795
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
|
ISO |
mRNA:increased expression:skin |
RGD |
PMID:14527737 |
RGD:8549525 |
NCBI chrNW_004955534:1,157,758...1,205,158
Ensembl chrNW_004955534:1,160,340...1,204,911
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20971924 PMID:21462799 |
RGD:8549521 RGD:8549556 |
NCBI chrNW_004955490:708,144...758,195
Ensembl chrNW_004955490:709,446...758,272
|
|
G |
Il17a |
interleukin 17A |
severity treatment |
ISO |
protein:increased expression:dermis, lymphocyte (human) protein:increased expression:epidermis (mouse) |
RGD |
PMID:18432274 PMID:22848348 PMID:24337738 |
RGD:8698670 RGD:9068417 RGD:9068436 |
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
|
|
G |
Il18 |
interleukin 18 |
no_association severity |
ISO |
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human) DNA:SNPs, haplotype: :rs795467, rs4937113, rs5744247 (human) protein:increased expression:serum |
RGD |
PMID:11490156 PMID:15317323 PMID:17517100 PMID:22840759 |
RGD:8655872 RGD:8655876 RGD:8655908 RGD:8655914 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il2 |
interleukin 2 |
susceptibility |
ISO |
associated with food hypersensitivity; protein:increased expression:CD8+ T cell: DNA:SNP:promoter:rs2069762(human) |
RGD |
PMID:1673687 PMID:7547077 PMID:16333313 PMID:16672002 PMID:21982597 |
RGD:8549583 RGD:8662961 RGD:8663444 RGD:8663473 RGD:8693325 |
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
protein:increased expression:skin |
RGD |
PMID:19075398 |
RGD:6892938 |
NCBI chrNW_004955493:5,613,704...5,646,692
Ensembl chrNW_004955493:5,613,564...5,650,583
|
|
G |
Il25 |
interleukin 25 |
|
ISO |
protein:increased expression:arm skin |
RGD |
PMID:23657503 |
RGD:39128244 |
NCBI chrNW_004955409:36,960,902...36,964,038
Ensembl chrNW_004955409:36,961,398...36,964,038
|
|
G |
Il31 |
interleukin 31 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955482:6,387,289...6,389,361
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955434:10,145,449...10,187,595
Ensembl chrNW_004955434:10,171,812...10,188,948
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
protein:increased expression:serum DNA:SNP:promoter:-590C>T (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:8363440 PMID:9643293 PMID:11886533 PMID:12230500 PMID:18249437 |
RGD:7829786 RGD:7829795 |
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Il4r |
interleukin 4 receptor |
susceptibility |
ISO |
DNA:mutation:cds:p.Q576R(human) |
RGD |
PMID:9392697 |
RGD:11530001 |
NCBI chrNW_004955493:5,546,340...5,580,745
Ensembl chrNW_004955493:5,545,944...5,582,422
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA: increased expression: skin |
CTD RGD |
PMID:11886533 PMID:18249437 PMID:22299064 |
RGD:5687175 |
NCBI chrNW_004955408:3,937,128...3,951,784
Ensembl chrNW_004955408:3,937,894...3,939,358
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18249437 |
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Kcnj11 |
potassium inwardly rectifying channel subfamily J member 11 |
|
ISO |
ClinVar Annotator: match by term: Atopic eczema |
ClinVar |
|
|
NCBI chrNW_004955414:32,209,426...32,212,424
Ensembl chrNW_004955414:32,210,545...32,211,717
|
|
G |
LOC102004294 |
cytochrome P450 4F22 |
|
ISO |
ClinVar Annotator: match by term: Atopic eczema |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955495:7,730,881...7,763,684
Ensembl chrNW_004955495:7,730,826...7,763,684
|
|
G |
LOC102010850 |
cytochrome P450 1A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27869817 |
|
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24046278 |
|
NCBI chrNW_004955556:1,593,552...1,705,543
Ensembl chrNW_004955556:1,593,494...1,665,784
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:polymorphisms:promoter, exon: |
RGD |
PMID:20642202 |
RGD:8693720 |
NCBI chrNW_004955425:7,704,371...7,708,951
Ensembl chrNW_004955425:7,702,137...7,709,006
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
|
RGD |
PMID:27776525 |
RGD:13204759 |
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
susceptibility |
ISO |
Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G |
RGD |
PMID:8817330 |
RGD:1599903 |
NCBI chrNW_004955511:4,377,894...4,400,797
Ensembl chrNW_004955511:4,380,502...4,400,852
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:17073871 |
RGD:8657069 |
NCBI chrNW_004955435:18,581,889...18,633,330
Ensembl chrNW_004955435:18,581,808...18,601,059
|
|
G |
Ngfr |
nerve growth factor receptor |
|
ISO |
protein:increased expression:nerve fibers of the papillary dermis |
RGD |
PMID:16586073 |
RGD:5508452 |
NCBI chrNW_004955451:12,030,303...12,047,305
Ensembl chrNW_004955451:12,030,252...12,047,305
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
ISO |
protein:increased expression:eosinophil |
RGD |
PMID:17223862 PMID:18647313 |
RGD:5144116 RGD:5684771 |
NCBI chrNW_004955545:2,929,704...2,947,579
Ensembl chrNW_004955545:2,929,704...2,947,579
|
|
G |
Ovol1 |
ovo like transcriptional repressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23042114 |
|
NCBI chrNW_004955422:19,524,420...19,528,938
Ensembl chrNW_004955422:19,522,384...19,534,450
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism potential therapeutic target with or without glucocorticoid therapy |
CTD RGD |
PMID:18249437 PMID:21633371 |
RGD:5509940 |
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
|
|
G |
Ppia |
peptidylprolyl isomerase A |
|
ISO |
mRNA:increased expression:zone of skin (human) |
RGD |
PMID:32496587 |
RGD:150383342 |
NCBI chrNW_004955456:7,381,923...7,383,203
|
|
G |
Relb |
RELB proto-oncogene, NF-kB subunit |
|
ISO |
|
RGD |
PMID:10940923 |
RGD:7777149 |
NCBI chrNW_004955555:2,060,533...2,086,229
Ensembl chrNW_004955555:2,060,533...2,086,229
|
|
G |
Sele |
selectin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12410700 |
|
NCBI chrNW_004955462:7,564,437...7,575,297
|
|
G |
Selp |
selectin P |
|
ISO |
atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:point_mutation:CDS:amino acid Val640Leu |
RGD |
PMID:12929084 |
RGD:1599904 |
NCBI chrNW_004955462:7,658,371...7,692,870
Ensembl chrNW_004955462:7,652,437...7,693,994
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16597321 |
|
NCBI chrNW_004955453:14,980,562...14,995,118
Ensembl chrNW_004955453:14,980,562...14,995,608
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15306842 |
|
NCBI chrNW_004955458:4,833,417...4,847,956
Ensembl chrNW_004955458:4,833,515...4,843,273
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
|
RGD |
PMID:11496247 |
RGD:7394812 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Tlr2 |
toll like receptor 2 |
severity |
ISO |
DNA:polymorphism: :-16934A>T(human) DNA:polymorphism:cds:p.R753Q(human) |
RGD |
PMID:17531301 PMID:19627277 PMID:22032785 |
RGD:8552997 RGD:8552999 RGD:8553048 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|